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PREFACE 
This dissertation is submitted for the degree of Doctor of Philosophy at the University of 
Copenhagen. The research was conducted under the supervision of Professor Lars Ove Dragsted 
and Professor Dan Stærk. The study was conducted at the Department of Nutrition, Exercise & 
Sports in collaboration with Department of Drug Design and Pharmacology as well as Department 
of Plant and Environmental Sciences, University of Copenhagen.  
This thesis presents the results from in vitro studies on inhibition of α-amylase and α-
glucosidase by some edible seaweeds and the effect of selected edible seaweeds on the 
postprandial blood glucose and insulin levels following a starch load in a human meal study. 
This dissertation contains several parts including the introduction and background on 
hyperglycaemia and seaweeds, the aims of the research project, material and methods, results 
(included papers), discussion, conclusion, and perspectives. 
The data from the thesis work has been gathered in 3 manuscripts included in the present 
thesis. Part of this study has been submitted in the following publications: 
Paper 1 
 Zaharudin, N., Salmaen, A.A., Dragsted, L.O. (2017). Inhibitory effects of edible 
seaweeds, polyphenolics and alginates on the activities of porcine pancreatic α-amylase. Food 
Chemistry. (Accepted). 
Paper 2 
Zaharudin, N., Staerk, D., Dragsted, L.O. (2017). Inhibition of α-glucosidase by selected 
edible seaweeds and fucoxanthin: Kinetic studies. Food Chemistry. (Submitted). 
Paper 3 
Zaharudin, N., Tulin, M., Sloth, J.J., Rasmussen, R.R., Dragsted, L.O. (2017). Effects of the 
edible seaweeds, Laminaria digitata and Undaria pinnatifida on postprandial glucose, insulin 
and appetite in humans. (Ready to submit). 
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SUMMARY 
Hyperglycaemia (high blood sugar levels) is one of the risk factor of type 2 diabetes (T2D) 
when it is sustained over a longer period of time. Various factors that can lead to high blood 
glucose levels include glucose absorption by the small intestine and the production of glucose by 
liver cells. Maintenance of normal plasma glucose concentration is essential for the human health. 
Diet and exercise play important role to control blood sugar level. Limiting intake of high 
Glycaemic Index (GI) foods as part of a balanced diet is known to be important. In addition, having 
the right food intake such ad functional foods that affect the blood sugar increase, e.g by containing 
inhibitors of α-amylase and/or α-glucosidase, may also help lowering the average blood sugar 
levels. Thus, such foods may in theory help to lower blood glucose postprandially and could 
potentially help delay the development of T2D in subjects with impaired glucose tolerance who 
regularly consume starchy foods.  
The present study involved the investigation of crude extracts of dried edible seaweeds in 
inhibiting the carbohydrate digestive enzymes, α-amylase and α-glucosidase. Bioactive 
compounds from selected edible seaweeds that inhibit α-amylase and α-glucosidase were 
identified. The edible seaweeds that were showing high potential for inhibiting the enzymes were 
selected to investigate their effect on the postprandial blood glucose and insulin levels following 
a starch load in a human meal study. 
In vitro studies and a human study were performed as part of this thesis. In Paper 1 and 
Paper 2, the inhibition of α-amylase and α-glucosidase activity in vitro by edible red, green and 
brown seaweeds were investigated. Aqueous and alcoholic extracts of dried edible seaweeds were 
tested to investigate the inhibition kinetics on these enzyme activities. The most potent edible 
seaweed extracts were showing mixed-type inhibition (lowering both Km and Vmax) and were 
selected for bioactive compound identification. The brown seaweeds, Laminaria digitata and 
Undaria pinnatifida, were found to be the most potent inhibitors of α-amylase and α-glucosidase 
activities. Polyphenols, alginates and fucoxanthin found in the selected seaweeds are among the 
bioactive compounds that contributed to inhibition of the enzyme activities. 
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In Paper 3, the same two edible seaweeds were tested in a human study. The primary 
endpoint was the ability of the edible seaweeds to reduce human postprandial blood glucose and 
insulin concentrations following a starch load in a human meal study. There was no significant 
effect in plasma glucose but both brown seaweeds lowered postprandial insulin response following 
consumption of Laminaria digitata or Undaria pinnatifida compared to the control meal. 
In conclusion, two brown seaweeds, Laminaria digitata and Undaria pinnatifida, inhibited 
α-amylase and α-glucosidase activities due to their content of several bioactive components with 
a potential use for future functional foods. Their effects on the postprandial insulin response and 
the in vitro findings regarding the phenolics, alginate and fucoxanthin in these seaweeds may 
further support that brown seaweeds, particularly Undaria pinatifida, might be used as a potential 
functional food to help control postprandial hyperinsulinaemia.  
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SAMMENDRAG (DANSK) 
Hyperglykæmi (højt blodsukker) over en længere periode er en risikofaktor for udvikling af 
type 2 diabetes (T2D). Blandt faktorer, der kan bidrage direkte til koncentrationen af glukose i 
blodet er absorptionen fra tyndtarmen og glukoneogenese i leveren. Kost og motion er vigtige for 
blodsukkeret. Fastholdelse af et normalt blodsukker er vigtigt for helbredet og begrænsning i 
indtaget af fødevarer med højt glykæmisk indeks som led i en sund og balanceret kost er kendt 
som vigtigt i forebyggelsen af T2D. Dertil kan indtag af visse fødevarer bidrage til at sænke 
blodsukkeret, herunder funktionelle fødevarer, der for eksempel indeholder hæmmere af -
amylase og/eller -glucosidase. Sådanne fødevarer kunne derfor i teorien hjælpe til at sænke 
blodsukkeret i perioden efter et måltid og kunne potentielt hjælpe med at forsinke udvikling af 
T2D hos personer som har en forstyrret glukosetolerance, men som har et hyppigt indtag af 
stivelsesholdige fødevarer.  
Arbejdet bag denne afhandling indbefatter studiet af, om simple ekstrakter af forskellige 
typer af spiselig tang (makroalger) kan hæmme fordøjelsesenzymerne, α-amylase og α-
glukosidase. Bioaktive komponenter i udvalgte spiselige makroalger med evnen til at hæmme 
disse enzymer blev identificeret. De arter af tang, der havde særligt stærk hæmmende effekt på 
enzymerne blev udvalgt til at studere effekten på blodsukker og -insulin, når de blev indtaget 
sammen med en belastning med stivelse i et måltidsstudie blandt frivillige forsøgspersoner. 
Denne afhandling omfatter derfor såvel in vitro studier som et humanstudie. I artikel 1 og 2 
undersøges effekten af røde, grønne og brune tangarter på aktiviteten af α-amylase og α-
glukosidase. Vandige og organiske ekstrakter af tørret tang blev anvendt i undersøgelsen af 
hæmningskinetikken. De mest aktive ekstrakter viste en blandet type af hæmningskinetik 
(sænkning af både Km og Vmax) og blev udvalgt til identifikation af de aktive komponenter. De 
brune makroalger, Laminaria digitata og Undaria pinnatifida, var de mest potente hæmmere af 
de to enzymaktiviteter. Polyphenoler, alginat og fucoxanthin fra de brune makroalger var blandt 
de komponenter, der bidrog til enzymhæmningen. 
I artikel 3 beskrives et måltidsstudie blandt frivillige med de samme to brune makroalger. 
Den primære hypotese var at de kunne sænke blodsukkeret efter en stivelsesbelastning og en af de 
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sekundære hypoteser var, at de kunne sænke blodets koncentration af insulin. Der var ingen effekt 
på blodglukose, mens der var en lavere stigning i insulin efter måltidet med brun tang, 
sammenlignet med kontrol (ærter). Der var tillige virkninger af tangen på følelsen af sult, appetit, 
mæthed og lysten til at spise noget. 
Det konkluderes, at de to makroalger, Laminaria digitata og Undaria pinnatifida, kan 
hæmme α-amylase og α-glukosidase som følge af deres indhold af visse bioaktive komponenter, 
hvilket giver dem potentiale som fremtidige funktionelle fødevarer. Deres virkninger på det 
postprandielle insulinrespons og virkningerne in vitro af fenoliske komponenter, alginat og 
fucoxanthin fra disse makroalger underbygger at brun tang og især Undaria pinnatifida i fremtiden 
potentielt vil kunne bruges i funktionelle fødevarer til at hjælpe med kontrol af postprandiel 
hyperinsulinæmi. 
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LIST OF ABBREVIATIONS 
 
 
ANOVA  Analysis of variance 
CBM3a Crystalline Cellulose-Binding Module 
CoMPP Comprehensive Microarray Polymer Profiling 
ESI Electrospray ionization 
FAME Fatty Acid Methylesters 
FAO  Food and Agricultural Organisation 
FDA  Food and Drugs Administration 
F-value  Fisher test value 
GAE  Gallic acid equivalent 
GI Glycaemic index 
GLP-1 Glucagon-like peptide-1 
HbA1c Hemoglobin A1c 
HPLC High Performance Liquid Chromatography 
HRMS High Resolution Mass Spectrometry 
IC50 Half maximal inhibitory concentration 
iAUC Incremental Area Under the Curve 
k  Rate constant 
Km Michaelis-Menten constant 
LM7 Monoclonal Antibody to Homogalacturonan 
P  Probability 
PHGG Partially hydrolysed guar gum 
pNPG p-nitrophenyl-beta-D-glucoside 
ppm  parts per million 
PTP1B protein-tyrosine phosphatase 1B 
R2  Co-efficient of determination 
rpm  revolutions per minute 
SCFA  Short-chain fatty acid 
SD  Standard deviation 
Spp.  Species 
T  Temperature  
t  Time  
T2D Type 2 diabetes 
TDF  Total dietary fibre 
TFC  Total flavonoid content 
TPC  Total phenolic content 
UV  Ultraviolet 
Vmax Maximum velocity 
wt/wt weight over weight 
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1. INTRODUCTION 
Diabetes mellitus (DM) is recognized as a major health problem, as it is the fastest growing 
chronic condition globally. It is one of the metabolic diseases characterized by hyperglycaemia 
resulting from defects in insulin secretion, insulin action, or both (American Diabetes Association, 
2009). The number of people with diabetes is growing worldwide and by 2040 it is estimated to 
rise to 642 million people (International Diabetes Federation, 2015). In Malaysia, 3.5 million (19.7 
%) of the citizens, aged ≥ 30 years are diagnosed with diabetes, showing an increase in the number 
of patients (World Health Organization, 2016). In Denmark, 320,545 (5.7 %) of the citizens are 
diagnosed with diabetes (Danish Diabetes Association, 2017). 
The upward trend of cases of diabetes has sparked awareness and worry in governments, 
that has prompted them to act to tackle this global health problem. The solution against this health 
problem requires researchers to do further studying on how to control, manage and treat this health 
problem.  
Early management of the condition by controlling high blood glucose levels 
(hyperglycaemia) as well as by maintaining a healthy lifestyle and making better choices in diet 
can halt the development of Type 2 Diabetes (T2D). Balanced diet and increased physical activity 
may lead to improvement or normalization of blood glucose levels. A diet with non-starchy foods 
or food with low glycaemic index (GI) has been introduced for people to improve glycaemic 
control and insulin sensitivity (Brand-Miller; Hayne, Petocz, 2003; McGonigal & Kapustin, 2008). 
Reducing glucose uptake or inhibition of glucose liberation has also been explored as a means to 
reduce hyperglycaemia (Kabir et al., 2014; Kasner, Hunter, Ph, Kariko, & Ph, 2013). It is of high 
interest to study how consuming food from natural sources containing carbohydrate digestive 
inhibitors may affect glucose uptake and metabolism. 
Marine-derived seaweeds may be one food candidate in terms of inhibitor content. The term 
“seaweed” refers to macroalgae and microalgae that belong to one of several groups of algae like 
red algae, green algae and brown algae (Baweja, Kumar, Sahoo, & Levine, 2016). Over the last 
decade, seaweeds have become ingredients in food and medicine (Fitton, Irhimeh, & Teas, 2007; 
Stengel & Walker, 2015). Seaweeds contain valuable nutrients and compounds such as fatty acids, 
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dietary fibres and polyphenols (Goñi, Valdivieso, & Garcia-Alonso, 2000; M. S. Kim, Kim, Choi, 
& Lee, 2008; B. Liu, Kongstad, Wiese, Jäger, & Staerk, 2016a; Lordan, Ross, & Stanton, 2011). 
Some of these bioactive compounds could be used for the management of hyperglycaemia. The 
identification of bioactive compounds from marine sources has seen increased interest among 
researchers of functional foods and in drug development. The application of seaweeds show an 
inhibiting effect on carbohydrate digestive enzyme activity in vitro (Gupta & Abu-Ghannam, 
2011; Ikeda & Kusano, 1983; Liu, Kongstad, Wiese, Jäger, & Staerk, 2016; Lordan, Smyth, Soler-
Vila, Stanton, & Ross, 2013).   
Therefore, the investigations and exploitation of seaweeds in in- vitro and human studies 
have been suggested, as it may provide valuable evidence, which could potentially be used in to 
control blood glucose levels. This thesis focuses on the effects of seaweeds on carbohydrate 
digestive enzymes in vitro and possible effects on human postprandial blood responses.  
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2. AIM OF THE THESIS 
The aims of this study were: 
1) To investigate the potential of crude extracts of dried edible seaweeds in inhibiting 
carbohydrate digestive enzymes (α-amylase and α-glucosidase). 
 
2)  To identify the bioactive compounds from selected edible seaweeds that inhibit α-
amylase and α-glucosidase. 
 
3) To investigate the effect of selected edible seaweeds on the postprandial blood glucose 
and insulin levels following a starch load in a human meal study. 
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3. BACKGROUND 
3.1 Hyperglycaemia  
Prolonged high blood glucose levels (hyperglycaemia) is a characteristic sign of diabetes 
mellitus (DM) (American Diabetes Association, 2009). Therefore, blood glucose control is the 
most important way in which to manage blood glucose levels. In general, a person is diagnosed 
with diabetes when their fasting plasma glucose concentration reaches ≥7.0 mmol/L or 126 mg/dL 
or when their two-hour plasma glucose ≥11.1 mmol/L or 200 mg/dL (International Diabetes 
Federation, 2015). HbA1c is an alternative (or even preferred) diagnostic for diabetes in recent 
criteria, especially from ADA in the US. In healthy non-diabetic individuals, postprandial 
hyperglycaemia is defined when the blood glucose level rises to >7.8 mmol/L (>140 mg/dL) 
(Monnier & Colette, 2015). 
Several factors may contribute to a higher blood glucose level. One of the factors is the 
individual’s diet, including the quality and quantity of carbohydrates (glycaemic load) in the diet 
(Giugliano, Ceriello, & Esposito, 2008; McGonigal & Kapustin, 2008). Food with high glycaemic 
index for instance rice or white bread result in higher postprandial rises in blood glucose and 
insulin compared with low glycaemic index foods (Tavani et al., 2003). The amount of insulin 
available and the degree of insulin resistance are another factor to consider when investigating 
blood glucose levels (American Diabetes Association, 2008). Insulin is a hormone released from 
the pancreas that is important in keeping the blood glucose level from getting too high or too low. 
If the body does not produce enough insulin or the cells are resistant to the effect of the hormone, 
the result will be an elevated blood glucose level (Aronoff, Berkowitz, Shreiner, & Want, 2004). 
Over time, insulin resistance may lead to type 2 diabetes (T2D) because of insufficient insulin to 
maintain blood glucose level to a normal level (Kahn, 2001).  
Studies have shown that postprandial hyperglycaemia may lead to complications of diabetes 
and to increased cardiovascular mortality (Giugliano et al., 2008; Monnier & Colette, 2015; De 
Vegt et al., 1999). An observational study done by Stratton (2000) revealed that the incidence of 
clinical complications in patients with T2D was significantly associated with previous 
hyperglycaemia.  Another study carried out by Cavalot et al. (2011) found that postprandial 
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hyperglycaemia predicts cardiovascular events in T2D with a 14-year follow-up. Therefore, 
controlling postprandial hyperglycaemia is very important when it comes to the management of 
the T2D.  
3.2 Carbohydrate digestion 
Carbohydrates 
Complex carbohydrates such as starch are polysaccharides made up of a mixture of long 
chains of glucose molecules and unbranched amylose (glucose residues linked by α-(1,4) bonds) 
and branched amylopectin (glucose residues linked by α-(1,4) and α-(1,6) branch points) (Figure 
1) (Hames & Hooper, 2005). Special enzymes such as -amylase break down starch into 
disaccharides such as maltose, which are in turn broken down by -glucosidases into 
monosaccharides such as glucose that can be absorbed by the intestines (Heacock et al., 2005).  
 
 
Figure 1. Structure of starch. Contains amylose and amylopectin with α-(1,4) bonds and α-(1,6) 
branching points. Adapted from Tester, Karkalas, & Qi (2004). 
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Digestion of carbohydrates in the mouth 
Digestion of polysaccharides such as starch begins in the mouth. Here, salivary α-amylase 
hydrolyses internal α-(1,4) glycosidic bonds in linear glucose polymers. However, α-amylase is 
unable to hydrolyse α-(1,6) linkages, α-(1,4) linkages near branch points, or terminal α-(1,4) 
linkages. Hence the primary end products of amylase digestion are oligosaccharides and 
disaccharides (Sanders, 2016). Some undigested carbohydrates travel down to the stomach. As 
these smaller carbohydrates such as trisaccharides and disaccharides go into the stomach, salivary 
amylase is inactivated by the acidic gastric juices and the digestion of carbohydrates does not 
recommence until they reach the small intestine. 
 
Digestion of carbohydrates in the small intestine 
As the carbohydrates pass into the small intestine, the gastric juices are neutralised by 
bicarbonate (HCO3-). Pancreatic α-amylase is released and digests the remaining starch digestion 
products. Similar to salivary α-amylase, pancreatic α-amylase is only able to hydrolyse linear 
portions of glucose polymers. Therefore, brush border enzymes (glucoamylase, sucrose-
isomaltase and glycosidase) are responsible for the next stage of the carbohydrate digestion 
(Sanders, 2016). Glucoamylase continues to hydrolyse starch with α-(1,4) linkages at the non-
reducing end of the glucose polymers to release individual glucose moieties such as a disaccharide 
of glucose bound by an α-(1,6) linkage and isomaltose (Sanders, 2016). Then, the small intestinal 
brush border enzyme, sucrase–isomaltase, hydrolyses α-(1,6) glycosidic bonds in isomaltose and 
α-(1-4) glycosidic bond in maltose, breaking down maltoses to glucose. Other functions of the 
sucrase-isomaltase is to digest sucrose into glucose and fructose, while the glycosidase enzyme, 
ß-glycosidase (lactase-phlorizin hydrolase), hydrolyses the ß-(1,4) bond of lactose to release the 
monosaccharides, glucose and galactose.  
The monosaccharide end products are quickly absorbed by the cells of the small intestine 
(enterocytes). The monosaccharides absorbed from the digestive tract enter into the bloodstream. 
The monosaccharides are then transported to the liver and the rest of the body (Sanders, 2016). 
Any carbohydrate that is not broken down by digestive enzymes and absorbed in the small intestine 
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such as resistant starch and dietary fibres will pass into the large intestine where they are fermented 
by microbes.  
3.3 Glucose metabolism and insulin resistance 
Blood glucose monitoring is essential for those who suffer from hyperglycaemia. A change 
of diet into one consisting of foods with a low glycaemic index (GI) is an important measure in 
maintaining stable blood glucose levels. Carbohydrates and their resulting glucose or other 
monosaccharide degradation products are an important part of the human diet. Therefore, 
understanding the process of maintaining a steady-state blood glucose level (homeostasis) is very 
important. 
 Plasma glucose concentration is a function of the rate of glucose entering the circulation 
balanced by the rate of glucose removal from the circulation. A steady-state blood glucose 
indicates equal rates of glucose production and utilization (Aronoff et al., 2004). This circulation 
of glucose is derived from the digestion of dietary carbohydrates, glycogenolysis and 
gluconeogenesis (Giugliano et al., 2008).  
The glucose from the digestion of starch described above, is transported by glucose 
transporters (GLUT2) and released into the blood stream (Campos, 2012). As the glucose levels 
in the blood increase, ß-cells in the pancreas respond by releasing insulin (Hames & Hooper, 
2005). Insulin controls the blood glucose level by activating the cell glucose absorption process 
and initiating storage of glucose in the muscles and liver as glycogen. It may be stored as glycogen, 
undergo glycolysis to yield energy and acetyl-coenzyme A, or be released into the circulation by 
the liver and kidneys (Poretsky, 2010). Excess glucose is also converted to fatty acids and stored 
as body fat. 
When blood glucose levels rise after ingesting a meal, insulin initiates absorption of glucose 
from the bloodstream or storage in the muscle, fat and liver cells. A deficiency in insulin secretion 
such as insulin resistance (IR) gives rise to elevated levels of glucose in the blood (Aronoff et al., 
2004). Over time, this abnormally high blood glucose level results in hyperglycaemia and can lead 
to prediabetes (Szablewski, 2001). Due to its reactivity, glucose binds to many proteins leading to 
their malfunction. This glycation can be used as a measure of continued hyperglycaemia and this 
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is why the relative abundance of glycated haemoglobin, HbA1c, is used as a diagnostic measure 
of hyperglycaemia and diabetes. 
3.4 Control and management of hyperglycaemia 
Untreated hyperglycaemia can cause long-term complications such as diabetes, kidney 
damage, nerve damage and eye problem (cataract) (Vieira-Potter, Karamichos, & Lee, 2016). The 
medical challenge posed by these complications is huge. Therefore, control and management plans 
are needed for maintaining blood glucose levels.  
Primary management such as nutritional interventions, physical activity and weight control 
is important for the management of blood glucose levels (Giugliano et al., 2008). Lifestyle 
modification studies have shown that adopting a healthy diet and physical activity can prevent or 
at least delay the onset of diabetes with a 43% reduction over a 20-year period (Li et al., 2008). 
Findings from another study demonstrated that diets with a low glycaemic load are beneficial in 
controlling high plasma glucose levels (Ceriello, Colagiuri, Gerich, & Tuomilehto, 2008). By 
reducing the consumption of sugary as well as fatty foods and increasing the consumption of 
dietary fibre volunteers can improve blood glucose levels (Khalid Imam, 2013). Having foods with 
a lower glycaemic index (GI) such as legumes, fruits, vegetables and food products that contain 
starches and sugars that are more slowly digested and absorbed helps to reduce hyperglycaemia 
(Giugliano et al., 2008). 
If needed, the use of oral glucose-lowering medication and food supplements is prescribed 
as another way to control high blood glucose levels. Monotherapy using α-amylase and/or α-
glucosidase inhibitors are types of medication that lower blood glucose levels in subjects having a 
starchy diet. Acarbose (Figure 2), is one of the medications that are used to inhibit carbohydrate 
digestive enzyme such as α-amylase and/or α-glucosidase through competitive inhibition 
(Heacock, Hertzler, Williams, & Wolf, 2005). The inhibition of these enzymes delays starch 
degradation and slows down the absorption of sugars, consequently, reducing postprandial 
glycaemia (Hu, Li, Lv, Wu, & Tong, 2015). Thus, it may help to delay the development of T2D 
in patients with impaired glucose tolerance who consume starch.  
19 
 
 
 
 
Figure 2. Acarbose. Adapted from Sales, Souza, Simeoni, & Magalhães (2012). 
 
A meta-analysis shows positive effects of acarbose in preventing the progression of 
prediabetes to diabetes and in reversing prediabetes to normal glucose tolerance in Eastern and 
Western populations (Hu et al., 2015). In another study, 7-month treatment with acarbose also 
improved glycaemic control and homeostasis model assessment insulin resistance index (HOMA-
IR), fasting plasma insulin, and post-prandial plasma insulin in type 2 diabetic patients (Derosa et 
al., 2011). Unfortunately, there are some side effects such as abdominal pain, flatulence, 
constipation and diarrhea from undigested starches because of the consumption of large doses of 
acarbose (Jones et al., 2011; Mertes, 2001). It is therefore advised to start with a low dose and 
gradually increase the dose to the desired amount. 
Similarly, other plant compounds have demonstrated bioactivity against hyperglycaemia 
including polyphenols, polysaccharides, alkaloids and glycosides. Anthocyanins for instance, 
extracted from black currant berries inhibited α-glucosidase activity in vitro and was as effective 
as acarbose (Boath, Stewart, & McDougall, 2012). In a study conducted by Goh et al. (2015), it 
was shown that catechins derived from green tea also inhibited the activity of α-amylase and α-
glucosidase. A study using male Wistar rats also showed that catechin solutions containing 
catechins from green tea (40-80 mg/mL) suppressed an increase in plasma glucose and increased 
plasma insulin and the activity of α-amylase (Matsumoto et al., 1993). Increasing the intake of 
dietary fibre might also be associated with the reduction of postprandial glucose levels and 
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increased insulin sensitivity (Weickert & Pfeiffer, 2008). The ability of dietary fibre to retard food 
digestion and nutrient absorption influences the carbohydrate metabolism. Evidence shows that by 
increasing the intake of fibre from sources such as cereal whole grain and oat that have a low in 
glycaemic index (GI) help to reduce the risk of metabolic syndrome, insulin resistance and obesity 
(Giacco, Costabile, & Riccardi, 2015; Lafiandra, Riccardi, & Shewry, 2014). An intervention 
study of 12 healthy subjects, given 6 g of partially hydrolysed guar gum (PHGG) for 12 months, 
showed significant reduction in postprandial plasma glucose and reduced the fasting and 
postprandial insulin levels (Kapoor, Ishihara, & Okubo, 2016). Barley that contains ß-glucans was 
fed to GK rats (male, type 2 diabetic) for 9 months and significantly improved the area under the 
plasma glucose concentration time curves and lowered the fasting plasma glucose level (Li et al., 
2003).  
High viscosity foods rich in dietary fibres may influence the glucose tolerance. For instance 
ß-glucan, which is highly viscous in solution increases the viscosity of contents in the stomach and 
small intestine (Gao et al., 2015; Lafiandra et al., 2014; J. Li et al., 2003). Increased viscosity of 
the intestinal bolus increases the resistance of the mucosal diffusion barrier and thereby slows 
gastric emptying rate and inhibits mixing and diffusion in the intestinal tract. This might prolong 
carbohydrate digestion and reduce the glucose absorption rate (Lafiandra et al., 2014). Dietary 
fibre can also significantly alter pro-glucagon gene expression and modulate glucagon-like 
peptide-1 (GLP-1) (Li et al., 2003). GLP-1 plays a significant role in the disposition of glucose 
absorbed from the gut and affects the basal islet output of glucagon and thereby also fasting 
glycaemia. 
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3.5 Seaweed 
Seaweeds, also known as macroalgae, can be categorised into three different types  
Rhodophyta (red), Phaeophyta (brown) and Chlorophyta (green) algae (MacArtain, 2007), (Figure 
3). There are more than 10,000 species of seaweeds found in the sea in areas from the warm tropics 
to the cold temperate seas (Mahadevan, 2015). Some of the species float on the water like 
Sargassum and Gracillia. Some of the seaweeds have adapted to live in tidal rock pools or around 
the shores. 
Seaweeds are harvested and cultivated for various purposes. About 13 million tons of 
seaweeds are harvested every year around the world, including China, Korea, Japan, Philippines, 
Indonesia, Malaysia, India, Norway and Ireland (Mahadevan, 2015). Around 83% of seaweeds are 
produced for food consumption (Craigie, 2011). They are consumed as food for coastal cuisines, 
herbal use, and medicine (Mohamed, Hashim, & Rahman, 2012). In western countries such as 
Iceland, Scotland, Ireland, France, Canada and North America, seaweeds have been used as food 
ingredients in bread, butter and milk while in Japan, China and Korea, seaweeds are used in soups 
and sushi rap (Mahadevan, 2015). 
3.5.1 Type of seaweeds used in the study 
Eucheuma cottonii 
Eucheuma cottonii, also known as Kappaphycus alvarezii, belongs to the red algae cultivated 
for the production of carrageenan (Baweja et al., 2016). E. Cottonii makes up 80% of the world’s 
carrageenan production used in the phycocolloid industry in the Philippines, Indonesia and 
Malaysia (Lobban & Harrison, 2012). This species grows in open ocean waters with high levels 
of water motion, salinities greater than 30% with water temperatures between 25-30⁰C (Doty, 
Caddy, & Santelices, 1986). This seaweed is collected and dried under the sun prior to 
transportation. It can be eaten fresh or used as a food ingredient. 
Sarcothalia crispata 
Sarcothalia crispata, also known as Iridaea ciliate, also belongs to the red algae, found in 
the eulittoral to the sublittoral zone, down to a depth of 10 m (McHugh, 2003). This species grows 
naturally and is harvested in Chile for export to the US, Europe and Asia (Bixler, Johndro, & 
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Falshaw, 2001; Marambio, Mansilla, Ávila, & Rosenfeld, 2014). S. crispata contains kappa-
carrageenan and lambda-carrageenan. They are used as a source of hydrocolloid for extracting 
carrageenan. The carrageenan extract of S. crispata, is used in dairy products as a stabilizing agent 
(Bixler et al., 2001). 
Sargassum polycystum 
Sargassum polycystum is one of the brown macroalgae. This seaweed is found in tropical 
and subtropical waters in China, Japan, Philippines, Malaysia and Indonesia in the midlittoral 
down to the sublittoral zone (Baweja et al., 2016; Stengel & Walker, 2015). It grows attached to 
rocks or shells and coral. S. Polycystum is characterised by having many branches and leaves  that 
form large floating islands that also gives the Sargasso Sea its name (Baweja et al., 2016; Liu, 
Heinrich, Myers, & Dworjanyn, 2012). In earlier times, sargassum was collected for use in 
Traditional Chinese Medicine as a herbal remedy for the treatment of goitre ( Liu et al., 2012). The 
high level of iodine in this and many other seaweeds obviously explains this empirical finding. 
Laminaria digitata 
Laminaria digitata, also known as one of the species used as kelp, is a type of brown seaweed 
that grows in cold temperate marine waters. It is the largest brown seaweed and thrives along the 
European littoral zone and in the northern Atlantic (Bartsch et al., 2008). Under normal conditions, 
it is to be found all year round with ideal habitats spread throughout Danish coastal zones and the 
entire coast of Norway (Raybaud et al., 2013). L. digitata can be described as variable in shape, 
with long stipe and a broad lamina (Lund, 2014). 
Undaria pinnatifida 
Undaria pinnatifida, also known as wakame, is a widely used seaweed in Japan (Gollasch, 
2006). U. pinnatifida is a species of brown seaweed with a deep dark greenish brown colour and 
leaves being 1-3 m long and 30-40 cm wide. It grows in the Pacific Northwest and in cold 
temperate coastal areas along Japan, China, and Korea (Verlaque, 2007). It grows in the upper part 
of the infralittoral zone down to 10-20 m and it can grow on the surface of rocks, shells, artificial 
pillars and sea walls (Bloch, 2014). U. pinatifida has been cultivated for hundreds of years in Japan 
23 
 
 
 
and Korea, and in recent years also in China. Subsequently France and Spain have started to 
cultivate this popular brown seaweed (McHugh, 2003). 
(a)                      (b) 
 
 
  (c)    (d)     (e)  
 
 
 
 
 
 
Figure 3. Various seaweeds used in the study. (a) Eucheuma cottonii; (b) Sarcothalia 
crispata; (c) Sargassum polycystum; (d) Laminaria digitata; and (e) Undaria pinnatifida. Adapted 
from Baweja et al. (2016); National Oceanic and Atmospheric Administration (2005); Wiktor & 
Tatarek (2007) . 
 
3.5.2 Application of seaweeds as human food 
In East Asian countries such as Japan, China, Korea, Taiwan and in South East Asian 
countries such as Thailand, Indonesia, Malaysia and Philippines, seaweeds are commonly used as 
food (Stengel & Walker, 2015). People who live in coastal areas in France, Scandinavia, South 
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West England, Ireland, and Scotland also consume seaweeds, albeit to a much more limited extent 
(McHugh, 2003; Stengel & Walker, 2015). 
Traditionally, seaweeds are serve as salads, vegetables, sushi wrap, used in soups (Table 1) 
and as traditional medicines (Liu et al., 2012). Today, seaweeds are also used for gelatinous 
substances in the food or pharmaceutical industries (Mohamed et al., 2012). It was reported that 
approximately 1 million tons of wet seaweed is harvested annually and extracted to produce 
hydrocolloids (McHugh, 2003). For instance, carrageenan or complex polysaccharides from 
seaweeds are extracted for the production of food gelling agents and preservatives (Ole G, 2015). 
Carrageenan is used in powdered form as gelling agent in chocolate milk, jam and preservatives 
in bread, meat and fish products (Fleurence, 2016; Lobban & Harrison, 2012; Roohinejad et al., 
2016).  Other than carrageenan, the hydrocolloids such as alginate, agar and fucoidan found in 
seaweeds are extracted as gelatinous substances, used as gelling and emulsifying agents (Mabeau 
& Fleurence, 1993; Rajapakse & Kim, 2011). Traditional use of kelp species has been for burning 
to produce sodium carbonate for the European glass and chemical industries. However, this was 
discontinued when cheaper sources became available in the 19th century. Relatively minor uses 
have included various food products. Modern use includes pilot scale biofuel production. 
 
Table 1. Seaweeds used as food ingredients 
Application Species Country References 
Soup 
Laminaria japonica,  
Undaria pinnatifida 
Japan, 
China, 
France 
(Bocanegra, Bastida, Benedí, 
Ródenas, & Sánchez-muniz, 2009; 
Mabeau & Fleurence, 1993) 
Sushi 
wrappers 
Undaria pinnatifida Japan, 
Korea, 
China 
(Lobban & Harrison, 2012; Teas, 
Vena, Cone, & Irhimeh, 2013) 
Salad Laminaria japonica, 
Gracilaria chorda, 
Undaria pinnatifida, 
Porphyra umbilicalis 
France, 
Japan 
(Fleurence, 2016; Mabeau & 
Fleurence, 1993) 
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Noodle Monostroma nitidum,  
Undaria pinnatifida 
Japan (Bocanegra et al., 2009; Ole G, 
2015) 
Alginate 
powder 
(pork 
products, 
beef 
products) 
Himanthalia 
elongata, 
Undaria pinnatifida 
 
Spain (Fernández-Martín, López-López, 
Cofrades, & Colmenero, 2009; 
López-López, Cofrades, Yakan, 
Solas, & Jiménez-Colmenero, 
2010) 
Carrageenan 
powder 
(bakery 
products, 
dairy 
products) 
Eucheuma cottonii, 
Chondrus crispus 
Philippine, 
Indonesia, 
Malaysia, 
Canada, 
France 
(Fleurence, 2016; Mahadevan, 
2015) 
 
3.5.3 Nutritional composition of edible seaweeds 
Seaweeds have a high fibre content and contain complex polysaccharides and mineral 
elements and a limited amount of lipids (Mabeau & Fleurence, 1993; MacArtain et al., 2007). The 
nutrient composition of seaweeds varies according to factors such as season, location, physiology, 
and species (Matanjun, Mohamed, Mustapha, & Muhammad, 2009). In Asian cuisines, the typical 
daily amount of seaweed consumed is 8 g on a dry matter basis (MacArtain et al., 2007).  Previous 
studies have analysed the nutrient composition of various edible seaweeds, including their 
micronutrients and macronutrients (Fleury & Lahaye, 1991; Lahaye, 1991; Mabeau & Fleurence, 
1993; Matanjun et al., 2009; Pereira, 2011). Table 2 shows the reported nutrient composition of 
edible seaweeds. The composition of one of the red seaweed species, S. crispata, has apparently 
not been reported so far. However, other red seaweeds have reported to have high content of 
protein (21-47% of dry weigh) (Rajapakse & Kim, 2011). 
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Table 2. Nutrient composition of dried edible seaweeds.  
Seaweeds Nutrient composition 
Carbohydrate 
(g/100 g dry 
weight) 
Soluble 
fibre  
(% dry 
weight 
sample) 
Insoluble 
fibre  
(% dry weight 
sample) 
Protein  
(g/100 g dry 
weight) 
The total fat content 
(% dry weight) 
 
E. cottonii 26.5a 18.3a 6.8a 9.7a 1.10a 
S. polycystum 33.5a 5.57a 34.1a 5.4a 0.29-2.19a,h 
L. digitata 48.0b 32.6c 4.7c 8.0-15.0e,g 1.0f 
U. pinnatifida 45.0-51.0b,g 30.0d 5.3d 11.0-24.0e,g 4.5f 
aValues from Matanjun et al., 2009. 
bValues from Pereira, 2011. 
cValues from Fleury & Lahaye, 1991. 
dValues from Lahaye, 1991. 
eValues from Joel Fleurence, 1999. 
fValues from Dawczynski, Schubert, & Jahreis, 2007. 
gValues from Burtin, 2003. 
hValues from Mwalugha, Wakibia, Kenji, & Mwasaru, 2015. 
 
Fibres and carbohydrate contents 
The average total dietary fibre content in edible seaweed is about 36-60% in dry condition 
(Rajapakse & Kim, 2011). Seaweeds are abundant in soluble fibres. Red seaweeds are rich in 
carrageenan and brown seaweeds are rich in alginates, fucoidan, and agar. These fibres cannot be 
digested completely in the human gut, thus help increase the feeling of satiety and aid digestive 
transit through their bulking capacity (MacArtain et al., 2007). Mac Artain and colleagues reported 
that L. digitata and U. pinnatifida contain more fibres than bananas and carrots. These seaweeds 
also do not contain a lot of carbohydrate, which might be causing them to have a negligible 
glycaemic load. High soluble fibre contents in seaweeds might be a potential functional food 
ingredient for lowering cholesterol and glycaemic index (Matanjun et al., 2009). The 
recommended average daily intake of dietary fibre in the United Kingdom is about 30 g and 25-
30 g in the United States (Brirish Nutrition Foundation, 2017; Rajapakse & Kim, 2011; WHO, 
2003). 
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Protein  
Generally, protein contents in seaweeds are rich in the amino acids, aspartic acid, glycine, 
arginine, alanine and glutamic acid (MacArtain et al., 2007; Rajapakse & Kim, 2011). L. digitata 
contains glutamic acid that gives rise to the umami taste (Mouritsen, Williams, Bjerregaard, & 
Duelund, 2012). The protein content in brown seaweeds such as L. digitata and U. pinnatifida is 
relatively high ranging from (8-24) g per 100 g dry weight compared with S. polycystum which 
contains only 5 g protein per 100 g dry weight (Fleurence, 1999; Matanjun et al., 2009).   
 
Lipids and fatty acids 
Most seaweeds contain polyunsaturated fatty acids such as linoleic acid (C18:2ω6). In U. 
pinnatifida, however, the concentration of linoleic acid is relatively low, varying from (0.3-4.2)% 
of total fatty acids (Dawczynski et al., 2007). Other polyunsaturated fatty acids found in U. 
pinnatifida and L. digitata are arachidonic acids (C20:4ω6) with concentrations in the range of 
(11.3-14.3)% (Dawczynski et al., 2007). L. digitata, E. cottonii and S. polycystum also contained 
essential fatty acids such as α-linolenic acid (C18:3ω3) (Liu, Kongstad, Wiese, Jäger, & Staerk, 
2016; Matanjun et al., 2009). According to Matanjun et al. (2009), E. cottonii also contained a 
high relative content of omega-3 fatty acids in the fat (45.72%) compared to S. polycystum 
(9.63%). 
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Minerals 
Seaweeds are known for their high mineral contents. Most seaweeds are high in calcium, 
magnesium, potassium, sodium, iron and iodine contents as shown in Table 3. Pereira (2011) and 
Matanjun et al. (2009) reported that U. pinnatifida and S. polycystum are rich in calcium, even 
higher than in milk and Laminaria species have a sodium/potassium ration that is optimal for 
humans. Seaweed such as L. digitata is also rich in magnesium with contents that are 6 times 
higher than that of carrots and tomatoes (mg/100g of dry weight) (Bocanegra et al., 2009). 
Seaweeds also contain large quantities of iodine; however, EU recommends establishing a safe 
upper iodine limit for seaweed products.  
Table 3. Mineral composition of seaweeds (mg/ 100 g dry weight) 
Seaweeds Mineral composition 
Sodium Calcium Potassium Iodine Magnesium 
E.cottonii 1771a 329a 13,155a 9.4a 271a 
S. polycystum 1362a 3792a 8371a 7.6a 487a 
L. digitata 3818b,d 1005b,d 11,579b,d 70c 659b,d 
U.pinnatifida 1600-7000b,d 680-1380b,d 5500-6810b,d 3.9c 405b,d 
aValues from Matanjun et al., 2009. 
bValues from Pereira, 2011. 
cValue from Institut de Phytonutrition, 2004. 
dValue from Rupérez, 2002. 
 
3.5.4 Bioactive compounds of seaweeds and their effect on glucose metabolism 
Seaweeds are not only rich in minerals; they have also become sources of many different 
chemical compounds that includes a variety of biologically active compounds. Table 4 shows the 
effect of seaweeds and their bioactive components on carbohydrate digestive enzymes and blood 
glucose levels. 
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Table 4. The effects of edible seaweeds on carbohydrate-digestive enzymes and glycaemic 
responses. 
Bioactive 
compound 
Seaweeds Experimental 
model 
Effect or 
mechanism of 
action 
References 
Fucoidan S. wightii α-D-glucosidase Inhibit α-D-
glucosidase     
(IC50 132.9 µg)  
(Vinoth 
Kumar et 
al., 2015) 
Fucoidan U. pinnatifida C57BL/KSJdb/db 
mice 
Reduced blood 
glucose levels in 
C57BL/KSJdb/db 
mice 
(Kim, 
Yoon, & 
Lee, 2012) 
Alginate L.digitata Large white male 
pigs 
Reduced blood 
glucose and 
insulin responses, 
50% decrease in 
glucose 
absorption 
balance over 8 h 
(Vaugelade 
et al., 2000) 
Sodium 
alginate 
Brown 
seaweed 
Men with 
noninsulin-
dependent 
diabetes 
Reduced the 
postprandial 
glycaemic 
responses 
(Torsdottir, 
Alpsten, 
Holm, 
Sandberg, 
& Tölli, 
1991) 
Polyphenols A. nodosum α-amylase and   
α-glucosidase 
Inhibited            
α-amylase and    
α-glucosidase, 
IC50 ~0.1 µg/mL 
GAE and         
IC50 ~20 µg/mL 
GAE,respectively 
(Nwosu et 
al., 2011; 
Pantidos, 
Boath, 
Lund, 
Conner, & 
McDougall, 
2014) 
Bromophenol G. elliptica α-glucosidase, 
rat-intestinal 
sucrose and rat 
intestinal maltase 
Inhibited α-
glucosidase (IC50: 
60.3-110.4 µM) 
and rat-intestinal 
(Kim, Nam, 
Kurihara, & 
Kim, 2008) 
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sucrose and rat 
intestinal maltase 
(IC50: 3.6-5.0 
mM) 
Fucoxanthin U. pinnatifida Female KK-Ay 
mice; Male 
C57BL/6J mice 
Significantly 
lowered blood 
glucose and 
plasma insulin 
levels in a dose 
dependent manner 
(Maeda, 
Hosokawa, 
Sashima, & 
Miyashita, 
2007; Park, 
Lee, Park, 
Shin, & 
Choi, 2011) 
 
Polysaccharides 
 There are two types of polysaccharides in seaweeds, those that are structural and those 
produced for storage. Seaweeds contain structural polysaccharides of the same type as surface 
plants, for examples cellulose and xylans while the storage polysaccharides consist of carrageenan, 
fucoidan and alginate, which exhibit textural and stabilizing properties for use in food application 
(MacArtain et al., 2007), Figure 4. Seaweeds contain an abundance of non-starch polysaccharides, 
potential sources of dietary fibre, prebiotics or other functional ingredients (Mabeau & Fleurence, 
1993). Seaweed fibres have positive impact on regulating the blood glucose levels as they could 
slow down the action of carbohydrates in the gut or starch digestion in the diet (Rajapakse & Kim, 
2011). According to Mabeau & Fleurence (1993) and Goñi, Valdivieso, & Garcia-Alonso (2000) 
the mode of action of soluble fibre may be to form viscous solutions. This could restrict the α-
amylase access to complex and simple carbohydrates and thus limit enzymatic breakdown of the 
starch molecules. This would enable soluble seaweed fibres to slow down digestion and absorption 
of nutrients thereby reducing blood glucose levels. 
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(a)                                                                     (b) 
             
Figure 4. Chemical structure of (a) Fucoidan; and (b) Alginate.  
Adapted from Jani (2009) and Padua, Rocha, Gargiulo, & Ramos (2015). 
 
Recently, seaweeds have been investigated for their potential as sources of enzyme 
inhibitors. Fucoidan (sulphated polysaccharides) found in brown seaweeds such as Ascophyllum 
nodosum have been identified as inhibitors of α-amylase and α-glucosidase (starch digestive 
enzymes), with IC50 0.013-0.047 mg/mL and IC50 0.12-4.64 mg/mL, respectively (Kim et al., 
2014). According to Kim et al. (2014), fucoidan could inhibit enzymes through electrostatic 
interaction between the negatively charged sulphate groups of fucoidan with the enzyme. A study 
conducted by Vinoth Kumar et al. (2015), also reported that fucoidan isolated from Sargassum 
wightii inhibited α-D-glucosidase with an IC50 of 132.9 µg/mL. 
Another seaweed fibre that is widely used in the food industry and tested on glycaemic 
regulation is sodium alginate. Sodium alginate consists of α-1-guluronic acid residues and ß-d-
mannuronic acid residues (Yavorska, 2012). The presence of guluronic acid residues allow 
alginate fibre to form viscous fluids by binding Ca2+ ions and stomach H+ ions (Milani & Maleki, 
2012; Yavorska, 2012). Consumption of viscosity raising fibre might hinder macronutrient 
absorption, slow gastric emptying and reduce postprandial glucose responses (Weickert & Pfeiffer, 
2008; Yavorska, 2012). An animal study done using different types of non-starch polysaccharides, 
showed that alginates (alginic acid) from L. digitata significantly reduced blood glucose 
absorption balance (50%) and insulin responses in pigs over 8 h (Vaugelade et al., 2000). 
Vaugelade and colleagues reported that this might be a product of the high viscosity 
polysaccharide in L. digitata compared with carrageenan from E. cottonii and xylans from 
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Palmaria palmate that could affect intestinal absorption of glucose and insulin response. Another 
study investigated crude polysaccharide obtained from Himanthalia elongata (Sea spaghetti), 
which significantly reduced blood glucose levels in alloxan-induced diabetic rabbits by 
approximately 50% and 18% in healthy rabbits after 8 h of 5 mg/kg intravenous administration 
(Lamela, Anca, Villar, Otero, & Calleja, 1989). In other work, fucoidan was isolated from the 
same species of seaweed (Himanthalia elongata) and shown to significantly lower blood glucose 
in healthy rabbits 8 h after intravenous administration of 2.5 mg/kg (27% reduction) ( Lamela, 
Anca, Vazquez-Freire, Gato, & Calleja, 1993). Another study done by Kim, Yoon, & Lee (2012)  
reported that highly sulphated fucoidan from the Sporophyll of U. pinnatifida  significantly 
reduced blood glucose levels in C57B/KSJm+/+db and C57BL/KSJdb/db mice. 
In a human study, the consumption of 5 g of sodium alginate in T2D-patients significantly 
reduced the postprandial rise in blood glucose and serum insulin by 31% and 42%, respectively 
(Torsdottir et al., 1991). According to this group, this attenuation of glycaemic response correlated 
with high doses of viscous fibre. The reduction in postprandial glycaemia might be a result of 
highly viscous fibre causing an increased viscosity of meal or stomach contents, a slowdown of 
the gastric emptying rate and a lowered intestinal absorption per second. A crossover study 
conducted in 14 healthy male subjects demonstrated that treatment with 1.5 g of strong-gelling 
sodium alginate reduces glucose concentration (Paxman, Richardson, Dettmar, & Corfe, 2008). 
Considering the above findings, seaweed fibre such as fucoidan and alginate found in brown 
seaweeds might be potent functional food ingredients for maintenance of blood glucose at near 
normal levels. 
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Polyphenol compounds 
 Previous research has suggested that functional groups of certain polyphenols from plants 
contribute to its biological importance and its efficacy in inhibition of starch digestive enzymes, 
as well as influence responses relevant to diabetes through modulation of glucose-induced 
oxidative stress (Lee & Jeon, 2013; Liu et al., 2016; Mojica et al., 2014; Nyambe-Silavwe et al., 
2015; Wojdyło, Nowicka, Carbonell-Barrachina, & Hernández, 2016). Some polyphenols, 
specifically flavonoids, phlorotannins and bromophenols, show potential α-amylase and α-
glucosidase inhibiting activities and have demonstrated anti-hyperglycaemic effects (Ibanez & 
Cifuentes, 2013; Lee & Jeon, 2013; Mojica et al., 2014; Pantidos et al., 2014). Seaweeds are potent 
sources of polyphenol compounds. Brown seaweed for instance contain phlorotannins (Figure 5), 
such as phlorofucofuroeckol, phloroeckols, eckol, dieckol and bieckol (Li, Wijesekara, Li, & Kim, 
2011; Lordan et al., 2011). While red and green seaweeds contain low levels of polyphenol 
compounds such as catechins and epicatechins (Murphy & Hotchkiss, 2015).  
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(a)                                                                  (b) 
                                                   
(c)                                                                     (d) 
                         
                                                           (e) 
 
Figure 5. Chemical structure of (a) eckol; (b) phlorofucofuroeckol; (c) 7-phloroeckol;     
(d) dieckol; and (e) 6,6-bieckol. Adapted from  Li et al. (2011). 
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Previous works reported that polyphenols from Ascophyllum inhibited amylase activity with 
IC50~ 0.1 µg GAE/mL. It also inhibited α-glucosidase activity in vitro at low doses, IC50~ 20µg 
GAE/mL and 10 µg/mL, respectively (Nwosu et al., 2011; Pantidos et al., 2014). Indeed, the 
phlorotannins from Ascophyllum extracts were more effective than acarbose, polyphenolic- rich 
extracts from teas (Yang & Kong, 2016), and berry fruits (Boath et al., 2012). In Eisenia bicylis, 
two phlorotannins, fucofuroeckol A and dioxinodehydroeckol, demonstrated significant inhibitory 
activities against α-glucosidase, with IC50 131.34 nmol/L and 93.33 nmol/L, respectively (Eom et 
al., 2012). Both bioactive compounds inhibited α-glucosidase activities in non-competitive 
inhibitions, where they competed with the substrate to bind to the active site. While in red seaweed, 
bromophenol purified from Grateloupia elliptica actively inhibited intestinal α-glucosidase, rat-
intestinal sucrase and rat-intestinal maltase (Kim, Nam, Kurihara, & Kim, 2008). In mouse models, 
polyphenol-rich extracts from Ascophyllum inhibited glucosidase and showed promising anti-
diabetic effects (Zhang et al., 2007). In summary, polyphenols and in particular the phlorotannins 
from brown and red seaweeds, show potential anti-hyperglycaemic effects through the inhibition 
of α-amylase and α-glucosidase activities. The inhibitory activities of phenolic compounds against 
starch digestive enzymes may be associated to their hydroxyl groups and be dependent on 
differences in the positions or the number of hydroxyl groups (Eom et al., 2012).  
 
Carotenoids 
Carotenoids are organic pigments that are found in phototropic organisms. Seaweeds contain 
carotenoids such as ß-carotene, lutein, zeaxanthin, astaxanthin and fucoxanthin (Ibanez & 
Cifuentes, 2013). Fucoxanthin is the main carotenoid found in brown seaweed, specifically in 
Undaria and Laminaria species (Maeda, Tsukui, Sashima, Hosokawa, & Miyashita, 2008). 
Fucoxanthin has an allenic bond and a 5,6-monoepoxide in the molecule (Maeda, Tsukui, Sashima, 
Hosokawa, & Miyashita, 2008), Figure 6.  
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Figure 6. Chemical structure of fucoxanthin. Adapted from Padua et al. (2015). 
Fucoxanthin has shown remarkable biological functions in animal model studies. It has been 
reported to have anti-obesity properties since it could help to attenuate the weight gain in white 
adipose tissue and to decrease the blood glucose level in obese and diabetic KK-Ay mice (Maeda 
et al., 2007; Mojica et al., 2014). A concentration of 0.02% fucoxanthin (wt/wt) significantly 
lowered plasma insulin, insulin resistance index and hepatic fat accumulation in (C57BL/6J) obese 
mice after 9 week regime (Park et al., 2011). These investigations showed that fucoxanthin has 
promising anti-hyperglycaemic effects, however more in-depth studies are needed to understand 
the mechanisms involved and the potential applications of this carotenoid in human health. 
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4. MATERIALS & METHODS 
4.1 Sample materials 
The seaweed species included in this study were selected based on a screening of different 
types of seaweeds that could be relevant for human health and consumption in Malaysia and 
Denmark. Most of these species are easily accessible and easy to use in the kitchen.  The dried 
edible seaweeds E. cottonii and S. polycystum were purchased from Malaysia, S. crispata was 
collected from the Department of Plant and Environmental Sciences, University of Copenhagen, 
Denmark while U. pinnatifida and L. digitata was purchased as described in Table 5.  
Table 5. Edible seaweed species used in this study, their class, origin and source. 
Species Class Type Country Source 
Eucheuma cottonii a  Rhodophyta Red Malaysia Purchased from The Borneo Local 
Product, Semporna, Sabah, Malaysia. 
Sargassum  
polycystum b 
Phaeophyta Brown Malaysia A generous gift from Uee Global Trade 
Sdn Bhd, Bkt Mertajam, Pulau Pinang, 
Malaysia. 
Laminaria digitata c Phaeophyta Brown Ireland Purchased from AlgAran Teoranta, 
Kilcar Co. Donegal, Ireland. 
Undaria pinnatifida d Phaeophyta Brown Korea Purchased from JFC Deutschland, 
Düsseldorf, Germany. 
Sarcothalia crispata e Rhodophyta Red Chile A generous gift from Danisco, 
Copenhagen, Denmark to Department of 
Plant and Environmental Sciences, 
Section for Plant Glycobiology, 
University of Copenhagen, Copenhagen, 
Denmark. 
aPurchased in June 2013; bReceived in June 2013; cPurchased in May 2013; dPurchased in August 2013; 
eCollected in August 2013 
 
The dried samples were washed with distilled water. They were freeze dried for 48 h using 
a freeze dryer (BFBT-101, Ontario, Canada). Next, the dried seaweeds were milled into powder 
at a frequency of 30 s-1 for 5 min by a TissueLyser II (Qiagen MM 200, Qiagen Nordic, West 
Sussex, UK). The powders were stored in the refrigerator at 2-4 ˚C for the next analysis. An 
overview of the experiments carried out in this study can be seen in Figure 7. 
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Figure 7. Experiments carried out in this study. 
4.2 Preparation of seaweed extracts for α-amylase and α-glucosidase inhibition assay 
The selection of solvents for extraction of seaweeds may depend on the type of the 
compounds targeted. In this study, water and alcohol were used to extract active ingredients from 
dried edible seaweeds, such as polyphenols and complex polysaccharides. As described in Paper 
1 and Paper 2, seaweed powders were extracted in three different solvents; water, 80% methanol 
and 70% acetone. The solvent-seaweed powder mixtures were extracted for 3 h and re-extracted 
for another 24 h. The mixtures were stirred using an orbital shaker at 140 rpm, at room temperature. 
After the extraction, the filtrates were evaporated using a rotary evaporator. The dried extracts 
were kept in the freezer for the analysis. 
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4.3 Identification of potent crude seaweed extracts on α-amylase and α-glucosidase 
inhibitory activities 
In this study, α-amylase and α-glucosidase inhibition using methanol, acetone and water 
extracts of seaweeds were determined as their percentage of enzymes inhibition and their IC50 
values. Stock solutions of all five seaweeds were prepared by dissolving the methanol and acetone 
extracts with dimethyl sulfoxide (DMSO). Water extracts were dissolved in 0.02 M sodium 
phosphate buffer solution. Acarbose was used as a positive control and as a negative control 
incubation mixture with no seaweed. The absorbances were measured for all samples, blank 
readings that contained no enzyme were subtracted from each well and results were compared to 
the control. 
The percentage of enzyme inhibition was calculated using the following equation: 
%100
control negative of Absorbance
sample) of Absorbance -control negative of e(Absorbanc
activity inhibitionenzyme%

 
 
IC50 values (defined as the inhibitor concentration that inhibits 50% of the enzyme activity) 
were determined graphically by interpolation from the inhibitions determined with different 
concentrations of seaweed extracts, as a percentage of inhibition versus log inhibitor concentration. 
The α-amylase inhibitory effects of seaweeds were measured at 0.05-50 mg/mL while the 
concentrations of seaweed extracts for α-glucosidase inhibitory effects were 0.005-50 mg/mL.  
4.4 Alpha-amylase inhibition assay 
The α-amylase inhibition was determined by an assay modified from a method developed 
by Wu (Wu et al., 2011) and Balasubramaniam (Balasubramaniam et al., 2013). A method of 
detection using dinitro salicylic acid (DNS) colour reagent, sodium phosphate buffer, starch 
solution, and seaweed extract was used for measuring the inhibition of porcine pancreatic α-
amylase, as described in detail in Paper 1. Each sample was placed in a 96-well microplate and 
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the α-amylase inhibitory activity was determined based on the colorimetric assay. The absorbance 
was recorded at 540 nm.  
4.5 Alpha-glucosidase inhibition assay 
The α-glucosidase inhibition assay was performed according to the method described in 
(Schmidt, Lauridsen, Dragsted, Nielsen, & Staerk, 2012). The inhibitory effects of 5 seaweed 
extracts were measured at lower concentrations. In each 96-well microplate, a solution of α-
glucosidase enzyme was mixed with seaweed extract and pNPG. The solution was then incubated 
at 28⁰C and the ratio of pNPG to p-nitrophenol was determined at 405 nm every 30 s for 35 minutes 
as described detail in Paper 2. 
4.6 Kinetics of enzyme inhibition 
The reaction rate and modes of inhibition of α-amylase and α-glucosidase by the different 
seaweed preparations were determined by Michaelis-Menten kinetics using Lineweaver-Burk 
plots. Initial reaction rate experiments were performed to determine the Michaelis constant (Km) 
and maximal velocity (Vmax). Michaelis-Menten kinetic parameters were determined using 
different concentrations of starch as a substrate 5.84-29.21 mM for α-amylase inhibition, while 
0.1-4.0 mM of pNPG for α-glucosidase inhibition. The substrates were each added into mixtures 
of seaweed extracts and enzymes. These experiments were performed as described in previous 
procedures for α-amylase and α-glucosidase inhibition assays (Balasubramaniam et al., 2013; 
Schmidt et al., 2012; Wu et al., 2011). The absorbance was measured immediately with a 
Multiscan FC microplate photometer to determine the initial reaction velocities, as described in 
Paper 1 and Paper 2. 
4.7 Identification of α-amylase inhibitors in seaweed extracts  
Seaweed extracts that show the most potent inhibitors of α-amylase and α-glucosidase 
activities with low IC50 and high percentage of inhibition were selected to identify their potent 
bioactive compounds. In this study, L. digitata and U. pinnatifida that showed strong inhibitory 
effects were selected for the identification of bioactive compounds. 
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Phenolic compounds 
As referred in Paper 1, total phenolic content in seaweed extracts were determined by using 
a modified Folin-Ciocalteu method (Singleton, Orthofer, & Lamuela-Raventós, 1999). The 
absorbance was measured at 765 nm on UV/VIS spectrometer Lambda 25 (PerkinElmer, Waltham, 
MA, USA). Standard (gallic acid) was used to construct calibration curve. The total phenolic 
content was expressed as mg gallic acid equivalents per mg of seaweed extract (mg GAE/mg).  
Polyphenolic compounds in seaweed extracts were then analysed on Reversed phase HPLC, 
Agilent 1200 series instrument (Santa Clara, CA). Polyphenolic compounds were identified by the 
retention time of chromatographic peaks compared with standards using the same HPLC operating 
conditions. Analytical grade standards of phenolic acids were used for further study of α-amylase 
inhibitory activity and kinetics. 
 
Complex carbohydrates 
 Further investigation using comprehensive microarray polymer profiling (CoMPP), a 
method from Sørensen & Willats (2011) and Torode et al. (2015) was applied to identify potent 
complex carbohydrates in selected edible seaweeds. This study was conducted at the Department 
of Plant Glycobiology, Faculty of Science, University of Copenhagen. The heatmap used in this 
experiment indicated mean plot signals, showing the relative binding of the monoclonal antibodies 
(mAb LM7, BAM1 and CBM3a) to seaweed extracts. High values of mean spot signals indicate a 
strong binding of monoclonal antibodies to seaweed extracts, again being an indicator of complex 
polysaccharides. LM7, CBM3a and BAM indicate that seaweed extracts contain alginate, cellulose 
and fucoidan, respectively. Detailed procedures are described in Paper 1. Complex 
polysaccharides were then extracted using a modified method originally developed by Fertah et 
al. (2014) and Torres et al. (2007). The yield of the complex polysaccharides was measured based 
on their dried biomass obtained after the extraction as the percentage of the seaweed dry weight 
(% dry wt). The dried extracts were then used for further study of α-amylase inhibition and its 
kinetics. 
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4.8 Identification of α-glucosidase inhibitors in seaweed extracts  
 
High-resolution α-glucosidase bio-chromatogram 
This study was conducted at the Department of Drug Design and Pharmacology, University 
of Copenhagen. A chromatographic separation of seaweed extracts was performed using a High-
Pressure Liquid Chromatograph (HPLC) (Agilent 1200 series) and fractionated at all time points 
during elution into 96-well microplates, leading to a resolution of data points per min, as described 
in Paper 2. The α-glucosidase inhibition for each well was determined as described above (α-
glucosidase inhibition assay). High-resolution inhibition profiles (cleavage rates) were plotted at 
selected retention times as a α-glucosidase inhibition bio-chromatogram underneath the HPLC 
chromatogram. 
 
Identification of active compounds using HPLC-HRMS 
Separation of seaweed extracts were performed using the same procedure, solvent 
composition, gradient profile, column, and temperature as described in the high-resolution α-
glucosidase biochromatogram’s procedure. HPLC-HRMS analysis of analytes with α-glucosidase 
activity was performed on the above-described chromatograph using a T-piece splitter to direct 
0.1% of the HPLC elute to a micrOTOF-Q II mass spectrometer (Bruker Daltonik, Bremen, 
Germany), equipped with an electrospray ionisation (ESI) interface, as described in detail in Paper 
2. Mass spectra were acquired in positive-ion mode.  
 
 
 
 
43 
 
 
 
4.9 Human meal studies 
Human meal study was conducted at the Department of Nutrition, Exercise & Sports, 
University of Copenhagen. The study was designed as a randomised, 3-way, blinded crossover 
trial. In total, 20 healthy participants completed the study. The test meal consisted of 150 mL of 
starchy drink, made up of 30 g of corn starch in water with 22 g of sugar free lemonade powder, 
with either of 3 different solid foods. The only difference between the meals was the addition of 5 
g of the seaweeds, Laminaria digitata or Undaria pinnatifida, or the addition of 5 g pea protein. 
Together with the test meal, a glass of 500 mL of water was served. 
The participants were instructed to eat only one type of meal each test day. The day before 
they received the meal, they had an overnight fasting period of 12 h. In the morning of each test 
day, the participants completed their first registration of subjective appetite sensations, the first 
blood sample was drawn, and the participants ate the test meal. Blood samples were drawn as 
follows: -20min (baseline) and then at 20, 40, 60, 90, 120 and 180 min. The blood was collected 
for plasma glucose and serum insulin analysis by standard clinical chemistry kits. Visual-analog 
scales (VAS) for a number of hunger- and satiety related feelings were also recorded intermittently 
for up to 3 h. After that an ad libitum meal consisting of pasta Bolognese was served and food 
intake was registered to calculate energy intake. Plasma glucose concentration was determined by 
a standard kit on an ABX Pentra 400 analyser (Horiba ABX SAS, Montpellier, Cedex, France). 
Insulin concentration was determined by a standard solid-phase, two-site chemiluminescent 
immunometric assay. GLP-1 was determined using ELISA; details about the human meal study 
are provided and discussed in Paper 3. 
The primary hypothesis was that the incremental area under the curve (iAUC) for plasma 
glucose would be lower after seaweed meals than after the placebo meal. Secondary endpoints are 
the iAUC for insulin, mixed-model postprandial analyses of differences in glucose and insulin, 
and the post-meal energy intake which were also hypothesized to be lower. 
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4.10 Determination of mineral elements and nutrient composition in seaweed samples 
The experiment to determine mineral elements in selected seaweeds was conducted at the 
National Food Institute, Technical University of Denmark. The concentration of selected mineral 
elements in the seaweed samples was determined following the principles in EN15762:2009 
(European Commitee for Standardisation, 2009) and EN15111:2007 (European Committee for 
Standardisation, 2005). The total element concentration was determined using inductively coupled 
plasma mass spectrometry (ICP-QQQ-MS) (Agilent 8800, Agilent Technologies, Waldbronn, 
Germany). Quantification was done using external calibration with internal standardization. 
Analytical quality was assessed by running selected samples in duplicate (RSD values in the range 
1-20% for all elements) and by the use of the certified reference material (CRM) ERM-CD200 
Bladderwrack  (IRMM, 2016). 
The analysis to determine the nutrient composition of test meals were conducted by Eurofins 
A/S (Glostrup, Denmark) and the results were compared with the nutrient composition from 
Dankost. Three test meals (L. digitata, U. pinnatifida and pea protein) were analysed for its 
contents of energy, protein, fat, carbohydrate and dietary fibre. 
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5.1 Paper 1: Inhibitory effects of edible seaweeds, polyphenolics and alginates on the 
activities of porcine pancreatic α-amylase 
Nazikussabah Zaharudin, Armando Asunción Salmeán, Lars Ove Dragsted 
Food Chemistry, November 2017 
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Abstract 
Edible seaweeds are valuable because of their organoleptic properties and complex polysaccharide 
content. A study was conducted to investigate the potential of dried edible seaweed extracts, its 
potential phenolic compounds and alginates for α-amylase inhibitory effects. The kinetics of 
inhibition was assessed in comparison with acarbose. The methanol extract of Laminaria digitata and 
the acetone extract of Undaria pinnatifida showed inhibitory activity against α-amylase, IC50 
0.74±0.02 mg/mL and 0.81±0.03 mg/mL, respectively; both showed mixed-type inhibition. Phenolic 
compound, 2,5-dihydroxybenzoic acid was found to be potent inhibitor of α-amylase with IC50 value 
of 0.046±0.004 mg/mL. Alginates found in brown seaweeds appeared to be potent inhibitors of α-
amylase activity with IC50 of (0.075±0.010 - 0.103±0.017) mg/mL, also a mixed-type inhibition. 
Overall, the findings provide information that crude extracts of brown edible seaweeds, phenolic 
compounds and alginates are potent α-amylase inhibitors, thereby potentially retarding glucose 
liberation from starches and alleviation of postprandial hyperglycaemia. 
KEYWORDS: Seaweed; Glucose liberation; α-Amylase; Phenolic compound; Alginate; Inhibitor; 
Hyperglycaemia 
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1.  Introduction 
Foods with a high glycaemic index (GI) such as simple carbohydrates, are rapidly digested and 
cause a rise in blood glucose levels (Opperman, Venter, Oosthuizen, Thompson, & Vorster, 2004). 
Enduring high blood glucose levels, known as hyperglycaemia, precedes type 2 diabetes mellitus 
(T2DM) (Oh, 2014). Dietary changes such as maintenance of a low dietary GI may aid in the 
prevention and management of hyperglycaemia. Another method to control blood glucose levels is 
through bioactive food components acting on the liberation of glucose during digestion. Inhibiting 
enzymes such as α-amylase is one such method for slowing down glucose liberation. It has previously 
been suggested that management of hyperglycaemia by inhibition of α-amylase may be used for the 
treatment or prevention of T2DM (Wu et al., 2011). Alpha-amylase found in pancreatic juice and 
saliva plays a significant role in the digestion of polysaccharides into maltose and glucose.  
Seaweeds are marine algae that are commonly used as vegetables in Asian countries. Seaweeds 
are also used as medicines and other therapeutic applications, while in Western countries they are 
used as a functional ingredients in foods and beverages (Gupta & Abu-Ghannam, 2011; Mabeau & 
Fleurence, 1993). Numerous studies have shown that seaweeds have significant nutritional value as 
well as potential health benefits. Seaweeds contain minerals, nutrients and non-nutrient components 
such as phenolic compounds and terpenoids (Stengel, Connan, & Popper, 2011; Syad, Shunmugiah, 
& Kasi, 2013).   In addition, seaweeds contain complex polysaccharides (alginate, carrageenan, 
fucoidan, agar, cellulose or xylan), which make up 30-71%, of their dry weight (Fleurence et al., 
2012; O’Sullivan et al., 2010). A study carried out in stable diabetes patients revealed that seaweed 
fibre (alginate) decreased the postprandial rise of blood glucose and insulin levels (Torsdottir, 
Alpsten, Holm, Sandberg, & Tölli, 1991) . Other more recent studies reported that fucoidan and 
cellulose were showing α-amylase inhibitory activity in vitro  (Kim, Rioux, & Turgeon, 2015; Dhital, 
Gidley, & Warren, 2015). Seaweeds are also known to have a low lipid content, only ~2.3% of their 
dry weight (Dawczynski, Schubert, & Jahreis, 2007). Since seaweeds contain complex 
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polysaccharides, which are resistant to enzymatic degradation by enzymes in the human body but 
undergo some degree of fermentation by the gut microbiota, consumption will slow down the release 
of absorbable monosaccharides such as glucose (Ramnani et al., 2012; Mohamed, Hashim, & 
Rahman, 2012). 
As seaweeds contain chemical constituents with potential for inhibition of α-amylase, these foods 
and food constituents might be beneficial in promoting health or management of hyperglycaemia. 
Therefore, in this study, we investigated the α-amylase inhibitory effects of dried seaweed sources 
from red and brown seaweeds (Sargassum polycystum, Laminaria digitata, Undaria pinnatifida, 
Eucheuma cottonii, and Sarcothalia crispata), some of which have not been studied previously. These 
seaweeds were selected due to their abundance and prevalent use as foods in Malaysia and in 
European countries such as Spain, Ireland, Norway and Denmark. In addition, we investigated the 
potential of phenolic compounds and alginates found in brown seaweeds as α-amylase inhibitor. This 
is the first study to clarify the enzyme kinetics of α-amylase inhibition by several edible seaweeds 
and to compare their inhibition kinetics with alginate and phenolic acids.  
2.  Materials and methods 
2.1  Chemicals 
Monoclonal antibodies (LM7, CBM3a or BAM1) were purchased from Paul Knox Cell Wall Lab, 
Centre for Plant Sciences, Faculty of Biological Sciences, University of Leeds, UK. HPLC grade 
acetonitrile and methanol, Folin-Ciocalteu’s reagent, standards of gallic acid, epicatechin, 2,5-
dihydroxybenzoic acid and epigallocatechin were purchased from Merck (Darmstadt, Germany). 
Porcine pancreatic α-amylase (EC 3.2.1.1), soluble starch (C12H22O11) (MW: 342.30 g/mol), 3, 5-
dinitrosalicylic acid (C7H4N2O7), acarbose, bromo-4-chloro-3-indolyphosphate (BCIP), nitro-blue 
tetrazolium chloride (NBT), diethanolamine, commercially available alginate (A7003) and all buffers 
and salts were purchased from Sigma-Aldrich (Schnelldorf, Germany).  
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2.2  Materials 
The dried edible seaweeds Eucheuma cottonii and Sargassum polycystum were imported from 
Malaysia, Sarcothalia crispata was collected from the Department of Plant and Environmental 
Sciences, University of Copenhagen, Denmark while Undaria pinnatifida and Laminaria digitata 
were purchased from Ireland and Germany, as described in the Supplementary data, Table S1. The 
collected samples were washed with distilled water and were frozen at –70 ⁰C for 24 h and dried for 
48 h using a freeze dryer (BFBT-101, Ontario, Canada).  The dried seaweeds were milled into powder 
at a frequency of 30 s-1 for 5 min by a TissueLyser II (Qiagen MM 200, Qiagen Nordic, West Sussex, 
UK). Seaweed powders were then stored in the refrigerator at 2-4 ˚C for up to 48 hours before 
analysis. – 
2.3  Preparation of seaweed extracts 
Separate portions (5 g) of each seaweed powder were extracted in 50 mL of methanol (80%), 50 
mL of acetone (70%) or 100 mL of water. During extraction, the solvent-seaweed powder mixtures 
were stirred using an orbital shaker at 140 rpm for 3 h at room temperature. Then, the methanol and 
acetone extracts were filtered using filter paper Whatman, Cat No 1001 125 (Frisenette, Knebel, 
Denmark) while the cold-water extract was filtered using a glass wool filter (18421 Glass wool, 
Sigma Aldrich, Schnelldorf, Germany). The residues were re-extracted for another 24 h under the 
same conditions and the filtrates from the first and second extractions were combined. The filtrates 
were evaporated using a rotary evaporator with a water bath temperature of 40 ⁰C (Büchi Rotavapor 
R-114 and water bath B-480 from Büchi Labortechnik AG, Flavil, Switzerland). The dried extracts 
were kept in the freezer at -20 ˚C within 48 hours for the analysis. In α-amylase inhibition assay, 200 
mg dried matter/ mL of stock solutions were prepared by dissolving the methanol and acetone extracts 
in 10% DMSO. The stock solution for dried aqueous extract was prepared by dissolving the extract 
in 0.02 M sodium phosphate buffer solution.  
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2.4  α-Amylase inhibition assay 
The α-amylase inhibitory activities of seaweeds were assayed using methods described by Wu et 
al. (2011) and (Balasubramaniam et al., 2013) with minor modifications. A volume of 100 µL of the 
diluted seaweed extract was mixed with 100 µL of porcine pancreatic α-amylase (0.5 U/mL of α-
amylase in 0.02 M sodium phosphate buffer with 0.06 M NaCl, pH 6.9 at 20˚ C) in 2 mL Eppendorf 
tubes. The mixture was pre-incubated at 25 ˚ C for 10 min. Acarbose (2 mg/mL) was used as a positive 
control. As a negative control (without seaweed extract), the sodium phosphate buffer was used for 
studies with water extracts and a mixture of 10% DMSO and sodium phosphate buffer was used for 
methanol and acetone extracts. After pre-incubation, 100 µL of 1% starch (dissolved in 0.02 M 
sodium phosphate buffer) was added into the solution and the mixture was incubated at 25 ˚C for 10 
min. Next, 200 µL of 96 mM dinitro salicylic acid (DNS) colour reagent was added. The mixture in 
the tubes were heated in boiling water for 5 min to stop the reaction and then cooled to room 
temperature. Finally, 200 µL of each incubation mixture was transferred into a well in a 96-well 
microtiter plate and the absorbance of the mixture was measured at 540 nm. The absorbance was 
measured with a Tecan Spectra III Rainbow reader (Tecan, Grodig, Austria) using Magellan Standard 
6.0 software.  
The percentage of α-amylase inhibition was calculated using the following equation: 
%100
control negative of Absorbance
sample) of Absorbance -control negative of e(Absorbanc
activity inhibitionamylaseα%    
IC50 values (defined as the inhibitor concentration that inhibits 50% of the enzyme activity) were 
determined graphically by interpolation from the inhibitions determined with different concentrations 
of seaweed extracts ranging from 0.05-50 mg/mL as percent of inhibition vs log inhibitor 
concentration (Gomathi, Kalaiselvi & Uma, 2012). 
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2.5  Kinetics of α-amylase inhibition 
The reaction rate and modes of inhibition of α-amylase by the different seaweed preparations were 
determined by Michaelis-Menten kinetics using Lineweaver-Burk plots. Experiments were 
performed to determine the Michaelis constant (Km) and maximal velocity (Vmax). This experiment 
was also performed in the 96- well microplates:  50 µl of starch solutions (5.84, 11.69, 17.53, 23.73 
and 29.21 mM) were added with 50 µL of 50 mg/mL seaweed extracts and 50 µl of 0.3 U/ml porcine 
pancreatic α-amylase. The absorbance was measured continuously with a Multiscan FC microplate 
photometer at 540 nm to determine the initial velocities. 
2.6  Determination of total phenolic contents 
The amount of total phenolic contents of selected seaweed extracts were determined according to 
the Folin-Ciocalteu method. Seaweed extract (1.0 mL) was mixed with 1.0 mL of Folin-Ciocalteu’s 
reagent and 5.0 mL of distilled water. The mixture was incubated for 5 min at room temperature. 
Next, 1.0 mL of 20% Na2CO3 was added to the mixture. The mixture was made up to 10.0 mL, and 
incubated for 1 h at room temperature. The absorbance was measured at 765 nm on UV/VIS 
spectrometer Lambda 25 (PerkinElmer, Waltham, MA, USA). Standard (gallic acid) was used to 
construct calibration curve. The total phenolic content was expressed as mg gallic acid equivalents 
per mg of seaweed extract (mg GAE/mg). 
2.7  Identification of phenolic acids by HPLC 
Chromatographic separation of seaweed extract was performed on a C18 column (Phenomenex, 
150 mm x 4.6 mm, i.d 3 µm) using HPLC, Agilent 1200 series instrument (Santa Clara, CA). The 
HPLC analysis was performed using eluent (A) consisted of water/acetic acid (99:1, v/v) and eluent 
(B) consisted water/acetonitrile/acetic acid (67:32:1, v/v/v). The injection volume of sample is 10 µL 
at 23 °C. The flow rate was 1 mL/min with the gradient profile: 0-10 min, 10% B; 10-16 min, 20% 
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B; 16-20 min, 40% B; 20-25 min, 50% B; 25-27 min, 40% B; 27-35 min, 10% B. UV trace was 
monitored at 275 nm. The identification of phenolic compounds in the chromatographic peaks were 
determined by the comparison of retention times with that of reference compounds. 
2.8  Identifying complex carbohydrates in selected seaweeds 
The composition of complex polysaccharides was analysed using comprehensive microarray 
polymer profiling (CoMPP), according to a published method (Moller et al., 2007; Salmeán et al., 
2017). The analysis involved sample extraction, spotting using a microarray robot, probing using 
monoclonal antibodies (mAb) and quantification using microarray software (ImaGene 6.0, 
Biodiscovery Inc., El Segundo, CA, USA).  The selected seaweeds were extracted 3 times by using 
the Alcohol insoluble residue (AIR) method. The collection of alcohol insoluble residue was 
performed by adding 5 mL of 70% ethanol to the powdered seaweeds and the mixtures were stirred 
for 1 h at 60 °C. The samples were centrifuged at 2500 x g for 10 min and the supernatants was 
discarded. This step was repeated until the supernatant was clear. Finally, the AIR samples were 
washed with acetone for 5 min and then air dried.  
The dried samples (10 mg) were placed in 96-tube boxes and metal ball bearings were placed in 
each tube. The samples in the tubes were homogenized with the TissueLyser II. A volume of 300 µL 
50 mM CDTA was added to each tube and the samples shaken at 30 Hz on the TissueLyser II for 2 
min before a 2 h extraction at 6-10 Hz. The boxes were then centrifuged at 2500 x g for 10 min and 
the supernatants were collected.  
Next, the samples were prepared for microarray printing. The extracted samples were printed onto 
nitrocellulose membranes using a microarray robot microarrayer robot (Piezoelectric Sprint 
Arrayjet, Roslin, UK). The membrane was cut into individual arrays and dissolved in 5 mL of 
blocking solution of 5% MP/PBS for 1 h. MP/PBS was discarded and 5 mL of primary mAb LM7, 
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BAM1 and carbohydrate binding protein (CBM3a) solution was added to extracted prints of each 
sample and left for 2 h. The mAb/CBM solution was discarded and the arrays were washed three 
times for 5 min in 10 mL PBS and 1 min in 10 mL deionised water on the orbit shaking table. Then, 
alkaline phosphatase (AP)-conjugated secondary mAb was added in 5 mL of MP/PBS and arrays 
were left at room temperature for 2 h.  After 2 h with secondary mAb, the arrays were washed as 
described above to remove excess antibody. Finally, these arrays were developed using development 
solution, which contained alkaline phosphate buffer and stored in the darkness until they were ready 
for development. Once developed, the arrays were removed from the development solution and were 
put in a water bath to stop the reaction and rinsed with deionised water for 3 min before placement 
on a filter paper to dry.  
For quantification of spot signals, the arrays were scanned on a standard commercial desktop 
flatbed scanner (CanoScan 9950F, Canon Denmark, Copenhagen, Denmark) at a resolution of 1200 
dpi and images were saved as 16-bit tiff files. The tiff files were uploaded into the Imagene microarray 
analysis software. The spot signals were converted into heatmaps using an online heatmapper tool 
(www.bar.utoronto.ca/ntools/cgi-bin/ntools_heatmapper.cgi). The complete data set that provided 
the maximal mean spot signals was set to 100%. 
2.9  Alginate extraction 
The extraction of alginate was performed through a modified method originally developed by 
Fertah et al. (2014) and Torres et al. (2007). Seaweed powder was suspended in 100 mL of 2% CaCl2. 
The solution was shaken for 1 h at 80°C using an orbital shaker at 240 rpm. After centrifugation at 
16,000 x g for 10 min, the supernatant was collected. The supernatant was mixed well with 2 mL of 
0.2 M HCl and the solution was shaken again using the same procedure as described above. The 
supernatant was then mixed with 5 mL of 3% NaC2CO3.  The solution was re-extracted for another 1 
h under the same conditions. The supernatants collected were labelled as crude extracts. The crude 
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extract was mixed with ethanol to obtain alginate. The solutions were then filtered, and the filtrates 
were dried using a rotary evaporator with a water bath temperature of 40⁰C (Büchi Rotavapor R-114 
and water bath B-480 from Büchi Labortechnik AG, Flavil, Switzerland). The yield of the alginate 
was measured based on their dried biomass obtained after the extraction as the percentage of the 
seaweed dry weight (% dry wt). The dried extracts were kept in the refrigerator at -20 ˚C within 48 
hours for the analysis. 
2.10  Statistical analysis 
The -amylase inhibition assays were performed in triplicate. Data was expressed as mean ± 
standard deviation. Statistical analysis was performed by using GraphPad Prism software (version 
6.0) (GraphPad Software Inc., San Diego, CA, USA) for IC50 and kinetic constants calculation. 
Values obtained were compared using Analysis of Variance (ANOVA). P-values were determined 
with corrections by Tukey’s multiple comparison and P < 0.05 was considered statistically 
significant. Kinetic constants were calculated in Excel and used to plot the Michaelis-Menten and 
Lineweaver-Burk plots.
3.  Results and discussion 
3.1  Alpha-amylase inhibition 
A comparative study was conducted to determine the ability of five species of seaweed extracts in 
three different solvents to inhibit α-amylase degradation of starch. As shown in Fig. 1, almost all 
seaweed extracts from, Eucheuma cottonii, Sargassum polycystum, Laminaria digitata, Undaria 
pinnatifida and Sarcothalia crispata showed the ability to inhibit porcine pancreatic α-amylase 
activity at a concentration of 2 mg/mL.  
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Fig. 1. α-Amylase inhibition using 2 mg/mL of seaweed extracts in methanol, acetone or water. Acarbose at 2 mg/mL 
was used as a positive control. Results were represented as mean ± standard deviation (n=3). Bars marked with different 
letters are significantly different at P < 0.05. 
The α-amylase inhibitory activity was found to be stronger with the methanol and acetone extracts 
than with water. The acetone extracts of Undaria pinnatifida showed the highest percentage inhibition 
of 69.3 ± 0.5% amongst the tested seaweed extracts, followed by methanolic extracts of Laminaria 
digitata with an inhibition of 61.5 ± 0.7% at 2 mg/mL (Fig. 1).  Acetone extract of Undaria 
pinnatifida and methanol extract of Laminaria digitata had significant (P < 0.05) inhibitory effect on 
α-amylase activity but lower than the commercial inhibitor, 2 mg/mL of acarbose (positive control), 
which inhibited the enzyme by 80.8 ± 0.5%. In contrast, the extracts of Eucheuma cottonii had the 
least inhibitory effect against α-amylase, less than 20% of inhibition at a concentration of 2 mg 
extract/mL. The aqueous extract of Eucheuma cottonii showed no α-amylase inhibitory activity. 
Overall, it is noted that brown seaweeds such as Undaria pinnatifida and Laminaria digitata had 
appreciable effects on pancreatic α-amylase (> 40%) compared with red seaweeds like Eucheuma 
cottonii and Sarcothalia crispata.  
Further data analysis was completed to determine the effectiveness of seaweed extracts in 
inhibiting α-amylase. The IC50 was calculated from the concentration-by-inhibition plots and the IC50 
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values are shown in Table 1. The standard inhibitor, acarbose was used as positive control (IC50=1.12 
± 0.04 mg/mL).  
Table 1  
IC50 values of seaweed extracts against α-amylase activities. 
 
The highest inhibitory activity was found in methanol extract of Laminaria digitata and in acetone 
extracts of Undaria pinnatifida with IC50 less than 1 mg/mL. The lowest inhibitory activity was 
exhibited by the water extract of Eucheuma cottonii where IC50 was more than 10 mg/mL and with a 
non-recordable inhibition even at this maximal concentration. It was found that brown edible 
seaweeds like Laminaria digitata and Undaria pinnatifda have considerable potential for inhibition 
of α-amylase with efficiencies better than the red seaweeds (Eucheuma cottonii and Sarcothalia 
crispata). In previous studies, brown seaweeds such as Ascophyllum nodosum and Fucus vesiculs 
were reported to have high α-amylase inhibitory activity with IC50 44.7 µg/ml and 59.1 µg/ml, 
respectively (Lordan, Smyth, Soler-Vila, Stanton, & Ross, 2013; Apostolidis et al. 2011; Apostolidis 
& Lee, 2010). According to Lordan et al. (2013), brown seaweeds (phaeophyceae) are an excellent 
source of α-amylase inhibitors and these seaweeds could tentatively slow down the activity of α-
amylase and decrease postprandial hyperglycaemia. These brown seaweeds may therefore have the 
potential to reduce the rate of α-amylase digestion of complex carbohydrates in the digestion system.  
Seaweed species IC50 (mg/mL) a, b 
Methanol Acetone Water 
Eucheuma cottonii 6.5 ± 0.2 5.7 ± 0.7 >10 
Sargassum polycystum 2.5 ± 0.0 2.8 ± 0.1 4.2 ± 0.5 
Laminaria digitata 0.74 ± 0.02 0.96 ± 0.03 3.2 ± 0.2 
Undaria pinnatifida 0.92 ± 0.02 0.81 ± 0.03 2.07 ± 0.1 
Sarcothalia crispata 4.6 ± 0.5 5.0 ± 0.5 6.3 ± 0.2 
aData are presented as mean ± standard deviation (n=3) 
bIC50 is the half maximal inhibitory concentration to produce 50% inhibition of the enzyme activity. 
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 The red seaweeds can also act as α-amylase inhibitors (Fig. 1). Inhibition of α-amylase activity is 
observed to increase in the order Eucheuma cottonii < Sarcothalia crispata. However, IC50 values are 
high (IC50 > 4 mg/mL) compared with brown seaweeds and acarbose, indicating that high 
concentrations of Eucheuma cottonii and Sarcothalia crispata are required to inhibit porcine 
pancreatic α-amylase.  The water extract of Eucheuma cottonii (2 mg/mL) slightly increased α-
amylase activity with no significant α-amylase inhibition at any concentration (Fig.1). As the 
inhibitor concentration was increased, the water extract of Eucheuma cottonii showed only negligible 
inhibitory effect (IC50 >10 mg/mL) indicating lack of efficacy.  
3.2  Alpha-amylase inhibition kinetics 
  A kinetic study was conducted to understand the type of inhibition exhibited by each seaweed 
extract.  Fig. 2 shows Lineweaver-Burk plots of a methanol extract of Laminaria digitata and an 
acetone extract of Undaria pinnatifida. Plots for other crude seaweed extracts are shown in the 
Supplementary data, Fig. S1-S3. The plots display 1/v versus 1/[S] where [S] is substrate concentration 
and v is the initial velocity of the reaction recorded according to Michaelis-Menten Kinetics. These 
plots provide values for the Michaelis-Menten constant (Km) and maximal velocity (Vmax).  
  
Fig.2. Lineweaver-Burk plots of inhibition kinetics of α-amylase inhibitory by (A) methanol extract of Laminaria digitata 
and (B) acetone extract of Undaria pinnatifida with variable starch concentrations (5.84, 11.69, 17.53, 23.73 and 29.21 
mM).
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These plots reveal mixed-type inhibition of α-amylase by the seaweed extracts, different from the 
competitive inhibition observed with acarbose. Undaria pinnatifida and Laminaria digitata display 
mixed-type inhibition since Km values were higher and Vmax values lower in comparison with control 
(inhibitor free) incubations. The addition of Undaria pinnatifida and Laminaria digitata extracts 
therefore most likely alter the Km and Vmax values by influencing the binding of substrates to the 
active sites. In mixed-type inhibition, a single inhibitor both hinders the binding of substrates and 
decreases the substrate turnover number for the enzyme (Berg, Tymoczko & Stryer, 2012), thereby 
providing a very robust inhibition. According to Narita & Inouye (2011), in a mixed-type inhibition, 
the apparent affinity of α-amylase for the substrate may either decrease or increase. In our case, since 
the Km values are high, this α-amylase has a decreased affinity for starch.  
3.3  Total phenolic content in selected seaweed extracts  
As reported in the present study, at 1 mg/mL extracts of Lamniaria digitata and Undaria 
pinnatifida significantly reduced α-amylase activity more than 50% inhibition. Hence, these two 
brown seaweeds were analysed for total phenolic content. The amount of total phenolic content is 
presented as in Table 2. 
Table 2 
Total phenolic content and the extraction yield of selected seaweeds. 
 Total Phenolic Content (mg GAE/g) Extraction yield (%) 
Seaweed Methanol Acetone Water Methanol Acetone Water 
Undaria pinnatifida 30.8 ± 1.2  12.5 ± 0.9  3.7 ± 0.6 17.5 ± 0.8 23.5 ± 1.0 28.6 ± 1.4 
Laminaria digitata 23.0 ± 1.1 7.6 ± 0.2 0.3 ± 0.0 19.2 ± 01.2 9.5 ± 0.6 54.3 ± 2.2 
Data are presented as mean ± standard deviation (n=3). 
 
 
The highest phenolic content was found in Undaria pinnatifida extract. In general, methanol 
extracts of both brown seaweeds contained significantly (P < 0.05) higher levels of phenolic contents 
when compared with water extracts. In previous studies, the aqueous extracts of Undaria and 
61 
 
Laminaria species were reported to have small values of phenolic content which is 8 mg/g GAE and 
0.1 mg/g GAE, respectively (Machu et al., 2015; Mojica et al., 2014). As reported by Machu et al. 
(2015), the amounts of total phenolic content are influenced by the origin and species of the sample, 
the type of solvents and the conditions of extraction. 
3.4  Identification of phenolic compounds  
Phenolic acids of Undaria pinnatifida and Laminaria digitata were identified by HPLC. As shown 
in Table 3, the major phenolic acids were found in Undaria pinnatifida extracts which contain higher 
amount of gallic acid, 2,5-dihydroxybenzoic acid, epicatechin and epigallocatechin compared to 
Laminaria digitata extracts. Both brown seaweed extracts contained higher amounts of 2,5-
dihydoxybenzoic acid compared to other phenolic compounds. Gallic acid was absent in acetone 
extract of Undaria pinnatifida. Water extracts of Undaria pinnatifida and Laminaria digitata 
generally contained low concentrations of phenolic compounds. 
Table 3 
Phenolic acids (mg/g extract) in seaweed extracts. 
Seaweed extracts Gallic 2,5-dihydroxybenzoic Epicatechin Epigallocatechin 
Undaria 
pinnatifida 
Water 0.8 ± 0.0 1.8 ± 0.1 1.4 ± 0.1 1.2 ± 0.2 
Methanol 4.3 ± 0.1 17.4 ± 1.3 5.8 ± 0.4 7.1 ± 0.2 
Acetone - 9.8 ± 0.2 2.5 ± 0.2 3.7 ± 0.1 
Laminaria 
digitata 
Water 0.3 ± 0.0 0.7 ± 0.0 - - 
Methanol 2.8 ± 0.6 13.9 ± 1.4 3.7 ± 0.5 0.9 ± 0.0 
Acetone 0.7 ± 0.0 5.3 ± 0.0 1.1 ± 0.4 - 
Result are expressed as mean ± standard deviation (n=3). 
 
In other studies, some of the phenolic compounds such as gallic acid, hydroxybenzoic acid, and 
caffeic acid have been identified in brown seaweeds.  Other researchers reported that Laminaria 
species contain lower gallic acid when compared to other brown seaweed such as Ascophyllum 
nodosum (Machu et al., 2015; Pantidos, Boath, Lund, Conner, & McDougall, 2014; Sabeena Farvin 
& Jacobsen, 2013). 
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3.5  Identification and quantification of selected seaweed polysaccharides  
Since brown seaweeds showed potent α-amylase inhibitory activities compared to red seaweeds, 
they were selected for further analysis to identify and quantify their complex polysaccharide content. 
Quantification of the mean spot signals (n=3) indicated some correlation between complex 
polysaccharide concentrations and signal. A heatmap is shown in Fig.3, indicating mean spot signals, 
and showing the relative binding of the LM7, CBM3a and BAM1 to Laminaria digitata, Undaria 
pinnatifida and Sargassum polycystum. 
 
Fig. 3. Heatmap with the relative binding of the LM7, CBM3a and BAM1 to Laminaria digitata and Undaria pinnatifida. 
The values in the heatmap are mean spot signals (n=3) and in all cases standard deviations were P < 0.1. The maximal 
value was set to 100. The colour scale is in relation to absorbance values. 
 
The mAb LM7 displays a strong binding to both Laminaria digitata and Undaria pinnatifida. This 
indicates a high concentration of alginates in Laminaria digitata and Undaria pinnatifida.  The mAb 
BAM1 also binds to these brown seaweeds but with lower mean spot signals, indicating 
comparatively smaller concentration of fucoidan.  
Findings in this study indicate that Laminaria digitata and Undaria pinnatifida contain high 
amounts of alginates and relatively smaller levels of fucoidans. As shown in another study 
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(Dawczynski et al., 2007), brown seaweeds contain alginate (1,4-linked polymer of β-D-mannuronic 
acid and α-L-guluronic acid).  Therefore, alginates from selected brown seaweeds were extracted for 
further study of α-amylase inhibitory activity and kinetics. 
3.6  The inhibition of α-amylase activities by phenolic acids and alginates  
In this study, gallic acid, 2,5-dihydroxybenzoic acid, epicatechin and epigallocatechin (analytical-
grade) that are potentially found in Undaria pinnatifida and Laminaria digitata (Table 3) were used 
to assess their ability to inhibit α-amylase activity. As in Table 4, 2,5-dihydroxybenzoic acid showed 
the most effective α-amylase inhibitor with IC50 0.046 ± 0.004 mg/mL. In accordance with the present 
result, previous study has demonstrated that hydroxybenzoic acid (400 mg/L) (analytical grade) 
inhibited amylase activity (Wu, Shen, Han, Liu, & Lu, 2009). Contrary to this, epigallocatechin 
showed the lowest α-amylase inhibitory activity (IC50 0.504 ± 0.003mg/mL). The finding is in 
agreement with Yilmazer-Musa et.al. (2015) findings which showed that catechin such as 
epigallocatechin is not a strong inhibitor for α-amylase. This may be due to the lack of specific A and 
B ring hydroxyl groups to effectively interact with the catalytic site of the enzyme (Goh et al., 2015; 
Piparo & Nestlé, 2008; Yilmazer-Musa et al., 2015).   
Table 4 showed potential inhibition against α-amylase of alginates. Alginates were extracted from 
Laminaria digitata and Undaria pinnatifida with yields of 2.7 ± 0.33% and 2.3 ± 0.41%, respectively. 
A commercial alginate (A7003) (0.0001-20 mg/mL) was used as a reference. All alginates were 
assessed for their ability to inhibit α-amylase. A dose-response curve for the commercially available 
alginate is shown in Fig.4. The commercial alginate inhibited α-amylase with lower IC50 0.096 ± 
0.001 mg/mL compared to crude extracts of Laminaria digitata.  
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Fig.4. Dose-response curve of commercially available alginate (A7003). Each point represents the average of triplicate 
measurements. 
 
Table 4  
IC50 values, Km and Vmax of samples. 
   Data are presented as mean ± standard deviation (n=3) 
To investigate the type of inhibition, Lineweaver-Burk plots were constructed. Kinetic analyses 
revealed that phenolic compounds such as 2,5-dihydroxybenzoic acid and gallic acid display mixed-
type inhibition while epicatechin and epigallocatechin are non-competitive inhibition (Table 4). The 
commercial alginate and alginates extracted from Laminaria digitata and Undaria pinnatifida are 
mixed-type α-amylase inhibitors, similar to the kinetics observed for the brown seaweeds. The 
inhibition obtained with phenolic acids and alginates might affect how the α-amylase interacts with 
Samples IC50 (mg/mL)  Type of inhibition Km (mM) Vmax (mM/ min) 
Phenolic acids     
Control (Without inhibitor) -   7.96 ± 0.52 0.4436 ± 0.0094 
Gallic acid 0.212 ± 0.049 Mixed-type 13.72 ± 1.69 0.3326 ± 0.0174 
2,5-dihydroxybenzoic acid 0.046 ± 0.004 Mixed-type 10.02 ± 1.20 0.2797 ± 0.0123 
Epicatechin 0.387 ± 0.011 Non-competitive 7.96 ± 0.77 0.3067 ± 0.0087 
Epigallocatechin 0.504 ± 0.013 Non-competitive 7.96 ± 0.46 0.3371 ± 0.0062 
Alginates     
Control (Without inhibitor) -  8.08 ±0.69 0.4864 ± 0.0133 
Commercial alginate 0.096 ± 0.001 Mixed-type 12.89 ± 1.26 0.4042 ± 0.0163 
Alginate (Laminaria digitata) 0.075 ± 0.010 Mixed-type 8.63 ± 0.79 0.3858 ± 0.0119 
Alginate (Undaria pinnatifida) 0.103 ± 0.017 Mixed-type 11.14 ± 1.33 0.4107 ± 0.0189 
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starch. As shown in Table 4, epicatechin and epigallocatechin show non-competitive inhibition as 
the Km values are unchanged and the Vmax values are decreased when compare with control sample.  
In non-competitive inhibition, epicatechin and epigallocatechin may react to an enzyme with or 
without a substrate and changes the conformation of an enzyme and the active site, thus slow the rate 
of reaction to form the enzyme-product. As for 2,5-dihydroxybenzoic acid, gallic acid and alginates, 
Km values increased with inhibitors since the inhibitors are competing with the substrates for a fixed 
number of active sites on α-amylase. Vmax decrease with the addition of 2,5-dihydroxybenzoic acid, 
gallic acid and alginates compared with control sample. These show that the inhibitors do not bind to 
the active site of the enzyme. Instead they bind allosterically, to different site of α-amylase, thus 
affecting the enzyme-substrate complex and slowing the rate of reaction between starch and α-
amylase.  
This finding may also be explained by the fact that the alginates that contain a linear polymer of 
uronic acid, mannuronic (M) and guluronic acid (G) can form acidic and ionic gels. This may 
influence the ability of digestive enzymes and gastrointestinal enzymes to interact with substrates, as 
reported by Houghton et al. (2015) and Wilcox et al. (2014). Alginate from Laminaria digitata has 
relatively high viscosity compared with carrageenans from Eucheuma cottonii, significantly affecting 
carbohydrate digestion (Vaugelade et al., 2000). Previous work has suggested that alginate contained 
in seaweeds produce viscous solutions and may be a barrier to starch digestion and influence glucose 
uptake (Goñi, Valdivieso & Garcia-Alonso, 2000; Nwosu et al., 2011). Previous studies also revealed 
that other complex polysaccharides such as the sulphated polysaccharide, fucoidan, from a brown 
seaweed (Ascophyllum nodosum) delays carbohydrate digestion and glucose absorption by limiting 
α-amylase activity or slowing the diffusion of glucose from the enzyme’s active site (Kim et al., 
2014). These findings suggest that alginate, which is an indigestible (resistant) polysaccharide, could 
be a useful component to inhibit α-amylase activity. 
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The brown seaweeds, Laminaria digitata and Undaria pinnatifida, tested in this study and another 
brown seaweed, Ascophyllum nodosum, tested by others, exhibited strong inhibitory activity against 
α-amylase. Although this would fit with their potential bioactive compound such as phenolic 
compounds and alginate content, it could also be a product of other mechanisms, such as other 
bioactive compounds found in the seaweeds since the organic rather than the water extracts were the 
most effective inhibitors. Although previous studies in the literature have reported on α-amylase 
inhibition by seaweeds, the strength of our present study is that we compare the inhibitory effects of 
edible brown and red seaweeds that come from five distinct genera (Laminaria, Undaria, Sargassum, 
Sarcothalia and Eucheuma). Different solvent extractions of seaweeds were compared in the present 
study to evaluate the efficacy of crude extracts for inhibiting α-amylase. In addition, enzyme kinetic 
studies were also conducted for the first time to provide information about the kinetics of α-amylase 
inhibition in the presence or absence of edible seaweeds, phenolic compounds and their main dietary 
fibre, alginate. However, further studies are recommended to validate the current findings taking all 
seaweed constituents into account. In vitro studies with human recombinant enzymes as well as 
human meal studies are also needed to confirm the external validity of the outcome of this research. 
4.  Conclusion 
Laminaria digitata and Undaria pinnatifida can be promising sources of dietary inhibitors of α-
amylase. The present study demonstrates that selected seaweeds inhibited porcine pancreatic α-
amylase through a mixed-type inhibition mechanism. The three brown seaweeds (Sargassum 
Polycystum, Laminaria digitata and Undaria pinnatifida) showed more potent α-amylase inhibition 
compared to two red seaweeds. This study also indicates that brown seaweeds containing 2,5-
dihydroxybenzoic acids, gallic acids and alginates may in general be potent inhibitors of α-amylase. 
The investigation provides in vitro evidence for α-amylase inhibitors from marine algae with details 
of the kinetic pattern of inhibition for the first time.  
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Table S1.  
Edible seaweeds used in this study, their class, origin and source. 
 
 
 
 
 
 
 
 
 
Species Class Type Country Source 
Eucheuma cottonii a  Rhodophyta Red Malaysia Purchased from The Borneo Local 
Product, Semporna,  
Sabah, Malaysia. 
Sargassum polycystum b Phaeophyta Brown Malaysia A generous gift from Uee Global Trade 
Sdn Bhd, Bkt Mertajam,  
Pulau Pinang, Malaysia. 
Laminaria digitata c Phaeophyta Brown Ireland Purchased from AlgAran Teoranta, 
Kilcar Co. Donegal, Ireland. 
Undaria pinnatifida d Phaeophyta Brown Korea Purchased from JFC Deutschland, 
Düsseldorf, Germany. 
Sarcothalia crispata e Rhodophyta Red Chile A generous gift from Danisco, 
Copenhagen, Denmark to  
Department of Plant and Environmental 
Sciences, Section for Plant 
Glycobiology, University of 
Copenhagen, Copenhagen, Denmark. 
a Purchased in June 2013; b Received in June 2013; c Purchased in May 2013; d Purchased in August 2013;  
e Collected in April 2013 
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Figure S1. Lineweaver-Burk plots of inhibition kinetics of α-amylase inhibitory by methanolic extracts of seaweeds, 
(A) Sargassum polycystum, (B) Undaria pinnatifida and (C) Sarcothalia crispata with variable starch concentrations 
(5.84, 11.69, 17.53, 23.73 and 29.21) mM. The values represent the mean ± standard deviation (n=3). 
(a) 
 
 (c) 
(b) 
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Figure S2. Lineweaver-Burk plots of inhibition kinetics of α-amylase inhibitory by acetone extracts of seaweeds,  (A) 
Sargassum polycystum and (B) Laminaria digitata with variable starch concentrations (5.84, 11.69, 17.53, 23.73 and 
29.21) mM. The values represent the mean ± standard deviation (n=3). 
(a) 
 
 
(b) 
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Figure S3. Lineweaver-Burk plots of inhibition kinetics of α-amylase inhibitory by aqueous extracts of seaweeds,  (A) 
Sargassum polycystum, (B) Laminaria digitata and (C) Undaria pinnatifida with variable starch concentrations (5.84, 
11.69, 17.53, 23.73 and 29.21) mM. The values represent the mean ± standard deviation (n=3). 
(a) 
 
 (c) 
(b) 
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Abstract 
Alpha-glucosidase inhibitors are used to control blood glucose levels for people suffering from 
hyperglycaemia. The inhibitors delay the breakdown of carbohydrate into simple sugars thus helping 
to lower blood glucose levels in people who have high blood glucose after eating. In this study, five 
species of dried edible seaweeds were tested for α-glucosidase inhibitory effect. A 5 mg/mL of 
methanol, acetone and water extracts of seaweeds were used for a high-resolution α-glucosidase 
inhibition assay hyphenated with high performance liquid chromatography-mass spectrometry 
(HPLC-ESI-MS). Our results show that acetone extracts of Undaria pinnatifida has the strongest 
inhibitory effect against α-glucosidase activity with IC50 0.08 ± 0.02 mg/mL. The active compound 
was identified as associated with the peak from fucoxanthin (IC50 0.0467 ± 0.0013 mg/mL). An 
inhibition kinetics study indicates that fucoxanthin is showing mixed-type inhibition. These results 
suggest that Undaria pinnatifida has a potential to inhibit α-glucosidase and may be used as a 
bioactive food ingredient for glycaemic control. 
KEYWORDS: Seaweed, glycaemic control, hyperglycaemia, α- glucosidase, fucoxanthin   
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1.  Introduction 
Prolonged high blood glucose levels (hyperglycaemia) is a characteristic sign of diabetes mellitus 
(DM) (American Diabetes Association, 2009). According to American Diabetes Association, (2009), 
the disorder is characterized by improper functioning or secretion of insulin hormone from the 
pancreas or abnormal glucose homeostasis. Excessive and frequent intake of quickly digestible 
carbohydrates may also lead to prolonged elevation in the blood glucose level (O’Keefe & Bell, 
2007). Over time, the continued postprandial state where the blood glucose is high (postprandial 
hyperglycaemia) may increase glycation and increase the risk of metabolic dysfunctions. In 
combination with other factors this may in turn increase the risk of type 2 diabetes where uncontrolled 
high blood glucose levels can contribute to a number of complications such as blindness, 
cardiovascular complications, renal failure, foot ulcers and need for limb amputation (Ceriello et al., 
2006; O’Keefe & Bell, 2007; Szablewski, 2001). 
It is important to control hyperglycaemia because it can contribute to serious complications. 
Hyperglycaemia can be managed by maintaining stable blood glucose levels inside the normal range. 
This can be achieved by various strategies such as diet, medications and exercise (O’Keefe & Bell, 
2007). Several life-style changes and medications have been introduced for managing 
hyperglycaemia. One of the strategies to manage the disorder is through inhibition of carbolytic 
enzymes such as α-amylase and α-glucosidase. Inhibiting these enzymes will result in slower 
absorption of sugars during digestion (Mojica, Meyer, Berhow, & de Mejía, 2015). Clinical studies 
using acarbose and miglitol as α-glucosidase inhibitors showed a reduction in postprandial blood 
glucose and an increase in insulin sensitivity (Su, Wang, Chen, Wu, & Jin, 2011; Meneilly et al., 
2000). These inhibitors act by blocking the α-glucosidase enzyme in the small intestine where 
breakdown of complex carbohydrates occur. This enzyme reaction reduces carbohydrate hydrolysis 
and glucose absorption into the bloodstream and thus lowering postprandial blood glucose levels 
83 
 
(Khalid Imam, 2013;  Ahmad, 2013). However, acarbose has side effects such as flatulence and 
abdominal pain (Rosenstock et al., 1998).  Such side effects are caused  by the fermentation of 
undigested carbohydrate by the microbiota in the large intestine (Khalid Imam, 2013; Samulitis, 
Goda, Lee, & Koldovsky, 1987). 
Besides acarbose many studies have been carried out to evaluate foods as a means to lower and 
control high blood glucose levels. The use of low glycaemic index foods in mixed meals (Grant, 
Wolever, O’Connor, Nisenbaum, & Josse, 2011), food intake with dietary fibre (Kapoor, Ishihara, & 
Okubo, 2016; Lattimer & Haub, 2010), intake of supplements and herbal medicines (Akilen, Tsiami, 
Devendra, & Robinson, 2012; Najm & Lie, 2010) have been shown to result in reduced blood glucose 
levels and an improvement in prevention of type 2 diabetes mellitus (T2DM). Natural sources that 
contain complex polysaccharides and potential bioactive compounds are also some of the food 
sources that can help regulate blood sugar and improve insulin sensitivity (Babio, Balanza, Basulto, 
Bullo, & Salas-Salvado, 2010; Valls et al., 2010; Wang, Zhao, Yang, Wang, & Kuang, 2016). It is 
reported that Salacia species inhibit α-glucosidase and slows the breakdown of carbohydrates into 
monosaccharides, thus lowering the postprandial blood glucose levels (Heacock, Hertzler, Williams, 
& Wolf, 2005; Matsuda H; Murakami T; Yashiro K; Yamahara J, 1999). A recent study also reported 
that plant extracts from Phyllantus species such as P. amarus and P. urinaria which are widely used 
in Vietnam as traditional medicines for diabetes showed the most promising inhibition of α-
glucosidase activity Trinh, Staerk, & Jäger (2016). Their findings provide additional evidences that 
inhibition of carbohydrate digestive enzymes such as α-glucosidase can be one of the means to control 
blood glucose levels by delaying the degradation of polysaccharides and starch to glucose (Lebovitz, 
1997). 
Marine algae such as seaweeds used as food sources in Asia, especially in Japan, Korea and China,  
are also providing similar potential health benefits (Pomin, 2012).  The present use of various species 
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of seaweeds as human foods from all parts of the world has seen a growing interest from researchers 
to study seaweeds as potential functional foods. Seaweeds contain nutrients such as dietary fibre, 
protein and biologically as well as potentially bioactive compounds like algal polysaccharides, 
phenolic compounds, carotenoids, and marine fatty acids (Ibanez & Cifuentes, 2013; Miyashita et al., 
2011; Sharifuddin, Chin, Lim, & Phang, 2015; Lordan, Ross, & Stanton, 2011). With this 
information, we undertook a study and applied selected edible seaweeds in order to evaluate their 
potential in inhibiting α-glucosidase activity.  
In this study, edible seaweeds were selected based on their availability. We selected five of the 
most commonly consumed brown and red seaweeds in Asia and Europe. Active compounds were 
extracted using three different polar solvents, methanol, acetone and water. The main aim was to 
investigate the potential of crude extracts from edible seaweeds in inhibiting α-glucosidase activity. 
Secondly, we wanted to identify the most potent α-glucosidase inhibitors and finally to evaluate the 
kinetics of inhibition. In addition, efficient techniques were applied to identify targeted α-glucosidase 
inhibitors using a high resolution α-glucosidase inhibition assay hyphenated with high performance 
liquid chromatography-mass spectrometry (HPLC-ESI-MS).  
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2.  Experimental 
2.1  Chemicals 
Alpha-glucosidase from Saccharomyces cerevisiae (EC 3.2.1.20), p-nitrophenol-α-D-
Glucopyranoside (pNPG), sodium azide, sodium phosphate monobasic dihydrate, dibasic sodium 
phosphate, dimethyl sulfoxide, acarbose and fucoxanthin were purchased from Sigma-Aldrich (St. 
Louis, MO). HPLC-grade acetonitrile and methanol were obtained from VWR International 
(Fontenay-sous-Bois, France). Water was prepared by deionization and 0.22 µm membrane filtration 
using a Millipore system (Billerica, MA). Methanol-d4 was purchased from Eurisotop (Gif-Sur-
Yvette, Cedex, France) and formic acid was purchased from Merck (Darmstadt, Germany). 
2.2  Sample material 
The dried edible seaweeds were purchased from companies in Malaysia, Ireland, Germany and 
Denmark or received from the Department of Plant and Environmental Sciences, University of 
Copenhagen, Denmark as described in Table 1. The dried samples were washed with distilled water.  
They were freeze dried for 48 h using a freeze dryer (BFBT-101, Ontario, Canada). Next, the dried 
seaweeds were milled into powder by a TissueLyser II (Qiagen MM 200, Qiagen Nordic, West 
Sussex, UK) at a frequency of 30 s-1 for 5 min. The powders were then stored in the refrigerator at 2-
4 ˚C for further analysis.  
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Table 1 
Seaweed species used in this study. 
Species Class Type Country Source 
Eucheuma cottonii a  Rhodophyta Red Malaysia Borneo Local Product, Semporna, 
Sabah, Malaysia. 
Sargassum 
polycystum b 
Phaeophyta Brown Malaysia Uee Global Trade Sdn Bhd, Bkt 
Mertajam, Pulau Pinang, Malaysia. 
Laminaria digitata c Phaeophyta Brown Ireland AlgAran Teoranta, Kilcar Co., 
Donegal, Ireland. 
Undaria pinnatifida d Phaeophyta Brown Korea JFC Deutschland, Düsseldorf, 
Germany. 
Sarcothalia crispata e Rhodophyta Red Chile Danisco, Copenhagen, Denmark and 
Department of Plant and 
Environmental Sciences, Section for 
Plant Glycobiology, University of 
Copenhagen, Copenhagen, Denmark. 
a Purchased in June 2013; b Received in June 2013; c Purchased in May 2013; d Purchased in August 
2013; e Received in August 2013. 
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2.3  Sample extraction 
A sample of 5 g of each seaweed powder, was extracted in 50 mL of methanol (80%), 50 mL of 
acetone (70 %) or 100 mL of water. The extraction mixtures were stirred using an orbital shaker at 
140 rpm for 3 h. Then the methanol and acetone extracts were filtered using filter paper (Whatman, 
Cat No 1001 125) while the water extracts were filtered using glass wool filters. The residues were 
re-extracted for 24 h under the same condition. All the filtrates were combined. The filtrates were 
dried using a rotary evaporator (90 mbar, 40⁰C) (Büchi Rotavapor R-114 and water bath B-480 from 
Büchi Labortechnik AG, Flavil, Switzerland). The dried extracts were kept at -20˚C for until analysis. 
Stock solutions of all five seaweeds were prepared by dissolving the methanol and acetone extracts 
with dimethyl sulfoxide (DMSO). Water extracts were dissolved in distilled water. Stock solutions 
of seaweed extracts (50 mg/mL) were prepared for α-glucosidase assays and HPLC analyses. 
2.4  Alpha-glucosidase inhibition assay 
The alpha-glucosidase inhibition assay was performed using a method from Schmidt et.al (2012). 
In a 96-well microplate, each well was added with 10 µl of extract dissolved in DMSO and 90 µl of 
0.1 M sodium phosphate buffer (SPB), pH 7.5 containing 0.02% sodium azide. A solution 80 µl of 
α-glucosidase (2.0 U/mL) in SPB was added in each well and the mixture was pre-incubated at 28 ˚C 
for 10 min. Acarbose was used as a positive control. As a negative control (without seaweed extract), 
sodium phosphate buffer was used for water extracts and a mixture of 10% DMSO and sodium 
phosphate buffer was used for methanol and acetone extracts. After the incubation, 20 µl of pNPG 
(dissolved in SPB) was mixed into the solution to initiate the reaction. The rate of pNPG conversion 
to p-nitrophenol was determined by the measurement of absorbance of p-nitrophenol at 405 nm every 
30 s for 35 minutes using a Multiskan FC microplate photometer (Thermo Fisher Scientific, Waltham, 
MA, USA) controlled by SkanIt software version 2.5.1.  
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The percentage of α-glucosidase inhibition was calculated by the following equation: 
%100
Slope
)Slope -   (Slope
inhibitioneglucosidasα%
blank
sampleblank
  
IC50 is the concentration at which the α-glucosidase enzyme activity is inhibited to 50% of 
maximum activity. The IC50 concentration was determined using different concentrations of seaweeds 
extracts, ranging from 0.005 - 50 mg/mL. These IC50 values were determined from the mean 
inhibitory values plotted in a graph of the percentage inhibition vs log inhibitor concentration 
(Gomathi et al., 2012). 
2.5  High-resolution α-glucosidase inhibition assay of seaweed extracts 
Experiments were performed according to a procedure developed previously with minor 
modifications (Schmidt, Lauridsen, Dragsted, Nielsen, & Staerk, 2012b). HPLC separation for high-
resolution α-glucosidase was performed using an Agilent 1200 series instrument (Santa Clara, CA) 
comprising a G1311A quaternary pump, a G1322A degasser, a G1316A thermostated column 
compartment, a G1315C photodiode-array detector, a G1367C high–performance auto sampler, and 
a G1364C fraction collector, controlled by Agilent Chemstation ver. B.03.02 software.  
A C18(2) Luna column (Phenomenex, 150 mm x 4.6 mm, 3 µm, 100 Å) was used for separation 
and maintained at 40 ⁰C with a flow of 0.5 mL/ min. The flow was maintained using a mixture of 
solvent A, acetonitrile: water (5%: 95%, v/v) and solvent B, acetonitrile: water, (95 %:  5%, v/v); 
both acidified with 0.1 % formic acid. A volume of 50 µl of (10 mg/mL) of acetone seaweed extract 
was injected and separated using the following gradient profile: 0 min, 0 % B; 40 min, 100 %; 50 
min, 100 %; 52 min, 0 % B; 55 min, 0 % B. UV traces were monitored at 210 nm, 254 nm, 280 nm, 
330 nm and 450 nm.  
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Micro-fractionations were performed using 96-well microplates. A total of 180 fractions were 
collected with HPLC eluate from 10 to 50 min (100 µl aliquot in each well). The fractionated solutions 
in the microplate were evaporated to dryness using a SPD121P Savant Speed-Vac concentrator 
(Thermo Scientific, Waltham, MA) equipped with an OFP400 Oil Free Pump and a RVT400 
Refrigerated Vapor Trap. The α-glucosidase assay was performed using contents in each well. 
Inhibition of α-glucosidase activity was plotted against chromatographic retention time to produce 
high-resolution biochromatogram. 
2.6  HPLC-HRMS analysis 
Separations were performed using the same solvents, gradient profile, column, and temperature as 
described above. HPLC-HRMS analysis of analytes with α-glucosidase activity was performed on 
the above-described chromatograph using a T-piece splitter to direct 0.1% of the HPLC elute to a 
micrOTOF-Q II mass spectrometer (Bruker Daltonik, Bremen, Germany), equipped with an 
electrospray ionisation (ESI) interface. Mass spectra were acquired in positive-ion mode using drying 
temperature of 200⁰C, capillary voltage of 4000V, nebulizer pressure of 2.0 bar, and drying gas flow 
of 7 L/min.  
2.7  Kinetics of α-glucosidase inhibition 
The reaction rate and modes of inhibition of α-glucosidase by the different seaweed extracts were 
determined by Michaelis-Menten kinetics using Lineweaver-Burk plots. Initial reaction rate 
experiments were performed to determine the Michaelis constant (Km) and maximal velocity (Vmax). 
This experiment was performed in 96-well microplates. The substrate, pNPG at concentrations of 
0.1-4.0 mM, was added into mixtures of seaweed extracts and α-glucosidase, as describe in the 
procedure for the α-glucosidase inhibition assay. The absorbance of p-nitrophenol was measured at 
405 nm for every 30 s for 35 minutes as described in the previous method.  
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2.8  Statistical analysis 
The α-glucosidase inhibition assays were performed in triplicate. All data was expressed as mean 
± standard deviation. Statistical analysis to calculate IC50 and kinetic constants was performed by 
using GraphPad Prism software (version 6.0) (GraphPad Software, Inc, San Diego, CA, USA). The 
Km and Vmax values obtained were compared using Analysis of Variance (ANOVA). P values were 
determined by Tukey’s multiple comparison test, where P < 0.05 was considered statistically 
significant. Linear Michaelis-Menten and Lineweaver-Burk plots were plotted in Excel (Microsoft 
Denmark, Kgs. Lyngby, Denmark) using the experimental kinetic values.   
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3.  Results and discussion 
 Alpha-glucosidase inhibitory activity 
The inhibition of α-glucosidase was found to be more effective with the acetone and methanol 
extracts. As seen in Fig. 1, the acetone extracts of Undaria pinnatifida showed the highest percentage 
inhibition of 92.04 ± 1.60% amongst the seaweeds extracts, followed by Laminaria digitata with 
inhibition of 64.15 ± 0.81% of the α-glucosidase activity. In comparison with that, 1 mg/mL of 
acarbose (positive control) inhibited the enzyme by 94.67 ± 1.65%. In contrast, the crude extracts of 
Eucheuma cottonii extracted in any of the three different solvents showed no inhibitory effect against 
α-glucosidase at a concentration of 5 mg extract/mL. In addition, it is noted that Undaria pinnatifida 
and Laminaria digitata had appreciable inhibition of α-glucosidase (> 50 %) compared with 
Sargassum polycystum and Sarcothalia crispata.  
 
 
Fig. 1. Bars show α-glucosidase inhibition by 5 mg/mL crude extract of seaweeds in 80% methanol, 70% acetone, 
and water. Acarbose (1 mg/mL) was used as a positive control. Bars represent mean ± standard deviation of three 
experiments. Bars marked with different letters are significantly different (P < 0.05). 
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Further data analysis was done to assess the effectiveness of seaweed extracts in inhibiting α-
glucosidase activity. The IC50 was calculated from the concentration-by-inhibition plots. As shown 
in Table 2, the IC50 of some of the seaweed extracts were comparable to those for the standard 
inhibitor, acarbose (IC50= 0.6 ± 0.01 mg/mL).  
Table 2. IC50 values of crude seaweeds extracts. 
Seaweed species α-glucosidase assay, IC50 (mg/mL)a,b,c 
80% methanol 70% acetone Water 
Eucheuma cottonii n.d. n.d. n.d. 
Sargassum polycystum 3.8 ± 0.3 n.d. 1.5 ± 0.2 
Laminaria digitata 1.6 ± 0.1  0.8 ± 1.5 >10 
Undaria pinnatifida 1.2 ± 0.2 0.08 ± 0.02  >10 
Sarcothalia crispata >10 n.d. >10 
aData is presented as mean ± standard deviation values of triplicate measurements. 
bIC50 is the concentration to produce 50% inhibition of the enzyme activity. 
c n.d.: not determined since there is no α-glucosidase inhibition at the maximal concentration, 5 mg/mL. 
 
The highest inhibitory activity was found in the acetone extract of Undaria pinnatifida with IC50 
less than 0.1 mg/mL. The acetone extract of Laminaria digitata also showed a potent α-glucosidase 
inhibitory activity with IC50 value of less than 1 mg/mL. The findings from this study showed that 
crude extracts of brown seaweeds, like Undaria pinnatifida and Laminaria digitata, have inhibitory 
effect on α-glucosidase activity. The results of this study also indicate that brown seaweeds are better 
inhibitors of α-glucosidase than red seaweeds like Sarcothalia crispata and Eucheuma cottonii. The 
inhibition of α-glucosidase activity is observed to increase in the order of Sarcothalia crispata < 
Sargassum polycystum <Laminaria digitata <Undaria pinnatifida. Suprisingly, Eucheuma cottonii 
was found to give rise to an increase in α-glucosidase activity compared to its respective negative 
control. The present findings seem to be consistent with other research, which found Undaria 
pinnatifida and Laminaria digitata showing more than 50% of α-glucosidase inhibitory activity (Liu, 
Kongstad, Wiese, Jäger, & Staerk, 2016). In contrast others found that water extract of Laminaria 
digitata was effective at inhibiting α-glucosidase (Lordan and colleagues 2013).  
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 High-resolution α-glucosidase inhibition profiling 
Our results demonstrate that a crude acetone extract of Undaria pinnatifida has the most potent 
inhibitory effect of α-glucosidase with high percentage inhibition (> 90%) and low IC50 value (< 0.1 
mg/mL) compared to other crude seaweed extracts. Therefore, we performed high-resolution α-
glucosidase profiling of the crude acetone extract of Undaria pinnatifida. High-resolution α-
glucosidase inhibition profile of this 70% acetone extract of Undaria pinnatifida overlaid with the 
HPLC chromatogram at 450 nm is shown in Fig. 2. 
 
Fig.2. High-resolution α-glucosidase inhibition profile of a 70% acetone extract of Undaria 
pinnatifida overlaid with the HPLC chromatogram at 450 nm. 
 
The potent α-glucosidase inhibitor (peak 1) found in Undaria pinnatifida was confirmed by HPLC-
HRMS analysis. A mass spectrum in positive mode ESI-MS was recorded from the peak at 
approximately 47 min in the UV-Vis chromatogram at 450 nm as shown in Fig. 3. 
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Fig.3. Chemical ionization mass spectrum (bottom) of the broad peak observed at approx. 47.6 
min (top) from the chromatogram of the most inhibitory acetone extract fraction from Undaria 
pinnatifida. 
The compound eluting as peak 1 with α-glucosidase inhibition of approximately 92% was 
identified from the mass spectrum as being fucoxanthin. It was found that fucoxanthin, which is a 
carotenoid from brown seaweed, had a high α-glucosidase inhibitory activity. Fucoxanthin 
(C42H58O6) extract was found at retention time, RT 47.6 min with m/z 659.43 (M+H)
+. The compound 
was confirmed by comparing the MS-data with spectral information. The finding of this active 
compound was in accordance with the literature (Palermo, Seldes, & Areschoug, 1991; Xiao, Si, 
Yuan, Xu, & Li, 2012). Fucoxanthin has previously been isolated from Eisenia bicyclis and Undaria 
pinnatifida and it showed potent inhibitory activity against PTP1B, which is another key therapeutic 
target in type 2 diabetes (Jung et al., 2012). However, this is the first report of the potent α-glucosidase 
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inhibitor of fucoxanthin from Undaria pinnatifida on its α-glucosidase inhibitory activity and type of 
inhibition.  
 Alpha-glucosidase inhibitory activity and inhibition kinetics of fucoxanthin 
Further analysis of the α-glucosidase inhibitory activity and the type of inhibition by a fucoxanthin 
standard was assessed. Fig.4 shows the dose-response curves with the IC50 value of 0.0710 ± 0.0021 
mM (0.0467 ± 0.0013 mg/mL). Fucoxanthin turns out to be a strong inhibitor for α-glucosidase 
activity with a lower IC50 value than that of the specific inhibitor acarbose (0.0592 ± 0.0015 mg/mL).  
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Fig.4. Dose-response (IC50) curve of fucoxanthin. 
Each point represents the average of triplicate 
measurements. 
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Fig.5. Lineweaver-Burk plots showing inhibition 
kinetics of α-glucosidase by fucoxanthin. 
 
The mode of inhibition was determined by Lineweaver-Burk plots (1/v versus 1/[S] where [S] 
analysis of data according to Michaelis-Menten Kinetics. As seen in Fig.5, the plots reveal mixed 
type of inhibition of α-glucosidase. This is based on Michaelis-Menten constant (Km) and maximal 
velocity (Vmax) values from the control incubation (free from inhibitor) and from incubations with 
fucoxanthin. The addition of a mixed inhibitor alters the Km and Vmax values by influencing the 
binding of substrates to the active site. In a mixed type inhibition, a single inhibitor both hinders the 
binding of substrates and decreases the turnover number of the enzyme (Berg, Tymoczko, & Stryer, 
2012). Fucoxanthin may therefore have the potential to reduce the rate at which α-glucosidase digests 
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complex carbohydrates in the small intestine. It has been reported that fucoxanthin lowered the fasting 
blood glucose concentration and plasma insulin concentration in C57BL/6J mice (Park, Lee, Park, 
Shin, & Choi, 2011).  Another study also reported that small amounts of purified fucoxanthin (0.2%) 
resulted in significantly lower blood glucose concentrations in KK-Ay mice (Maeda, Hosokawa, 
Sashima, & Miyashita, 2007); (Maeda, Tsukui, Sashima, Hosokawa, & Miyashita, 2008). 
4.  Conclusion 
The crude extract of brown seaweeds could be a promising source of α-glucosidase activity 
inhibitor. The present study demonstrated that fucoxanthin from Undaria pinnatifida is the specific 
compound responsible for the inhibition of α-glucosidase activity through mixed type inhibition. In 
addition, other brown seaweeds like Laminaria digitata and Sargassum polycystum showed potent 
inhibitory effect compared to red seaweeds. The investigation provides in vitro evidence for α-
glucosidase inhibitors from marine algae and its kinetic pattern that could be used for future animal 
and human studies. Nevertheless, more studies are needed to discover the ability of other carotenoids 
to inhibit alpha-glucosidase. Further investigation is also needed to understand if extracts from brown 
seaweeds could inhibit other carbolytic enzymes. 
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Abstract 
Background: High habitual consumption of carbohydrate with a high glycaemic index (GI) may 
cause unintended hyperglycaemia and be a factor off-setting glucose homeostasis. Starch has a high 
GI liberating glucose by the fast action of the digestive enzymes, alpha-amylase and beta-
glucosidase. Low-GI carbohydrate sources from seaweed with high nutrient contents may be 
efficacious for a glycaemic management strategy. Seaweeds also contain factors that may affect 
glycaemia as well as appetite.   
Objective: We investigated the effect of the two brown edible seaweeds, Laminaria digitata and 
Undaria pinnatifida, on postprandial blood glucose, insulin concentrations, GLP-1 secretion and 
appetite following a starch load in a human meal study.  
Method: We selected the seaweed species based on their culinary popularity, concentrated 
nutritional content, and potential for reducing glycaemia. Twenty healthy subjects were enrolled in 
a randomized, 3-way, blinded crossover trial. After an overnight fasting period of 12 h, the subjects 
received at each session one of three meals comprising 30 g of linear corn starch with 5 g of L. 
digitata or U. pinnatifida or an energy-adjusted control meal. Fasting and postprandial blood 
glucose, insulin and glucagon like peptide 1 (GLP-1) concentrations were measured over a period 
of 180 min and 120 min, respectively. Aspects of subjective appetite sensation were scored 9 times 
from baseline to 180 min using visual analogue scales (VAS). An ad libitum meal was served after 
this time in order to assess hunger more objectively. The change over time by mixed model 
analyses and the incremental area under the curve (iAUC) for plasma glucose, insulin, GLP-1 and 
VAS scores were compared between the seaweed test meals and the control meal. 
Results: There was no significant effect observed in plasma glucose and serum log-insulin iAUC 
response following consumption of L. digitata or U. pinnatifida compared to the control meal. 
However, linear mixed model (LME) analysis showed that log-insulin was reduced after intake of 
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U. pinnatifida overall and at time 20 min and 40 min after the test meal. LME and iAUC was 
increased for serum GLP-1 after intake of L. digitata compared to control and LME analysis 
specifically showed an increase at 120 min. Increase was observed also for iAUC and LME for 
satiety and fullness; LME analysis further showed increases at time 20 min for satiety and at time 
20 and 50 min and for fullness after intake of U. pinnatifida compared to control. Also the 
perception of fullness was amplified at time 20 min after intake of L. digitata compared to control. 
Intake of U. pinnatifida showed reduction in iAUC and from the the LME analysis at time 20 and 
70 min for hunger. iAUC was reduced for prospective food consumption; the LME analysis showed 
reduction between 20 to100 min after intake of U. pinnatifida compared to control. 
Conclusions: The brown seaweeds, L.  digitata and U. pinnatifida did not lower plasma glucose 
after a single meal but lowered plasma insulin and GLP-1 while increasing satiety and fullness as 
well as reducing feelings of hunger and prospective food intake compared to control. Thus, these 
brown seaweeds may play an important role in improving glycaemic and appetite control in healthy 
adults.  
 
KEYWORDS: Seaweed, Glycaemic response, Insulin response, GLP-1 secretion, Appetite, Satiety, 
Hunger
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1.  Introduction 
Postprandial hyperglycaemia is characterised by a plasma glucose level > 7.8 mmol/L (140 
mg/dL) 2 h after ingestion of food (Ceriello, Colagiuri, Gerich, & Tuomilehto, 2008). Normal 
fasting blood glucose levels are typically < 6.1 mmol/L with 2-h postprandial plasma glucose < 7.8 
mmol/L (postprandial) (WHO, 2006). Continued fasting and/or postprandial hyperglycaemia is 
characterised by a progressive decline in hepatic and peripheral insulin sensitivity, deterioration of 
β-cells, and deficiencies in the incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-
dependent gastric inhibitory peptide (GIP), secreted by the gut (Ceriello et al., 2008). Restoring a 
normal blood glucose level within a short interval after a meal is important for health, as 
hyperglycaemia is associated with increased risk of type 2 diabetes and the condition may therefore 
be a predecessor for diabetes development (American Diabetes Association, 2009). Therefore, 
minimising postprandial exposures to high blood glucose levels through dietary modification is one 
of the remedies for glycaemic management. 
In recent years, attention has increased to the potential health benefits and therapeutic properties 
of seaweed. For centuries, seaweed has been consumed in Asian countries such as China, Malaysia 
and Japan where they are a frequent ingredient in the daily diet. Remnants of edible seaweed 
species such as Arame (Eisenia bicyclis), Hiziki (Hizika fusiforme) and several Hondawara species 
such as Sargassum species have been found at archaeological excavation sites being ten thousand 
years old (Bocanegra et al., 2009). Elsewhere in the world, other seaboard countries such as Ireland, 
Scotland, Wales, Iceland, Norway, Canada and Spain have traditionally eaten seaweed but to a 
lesser extent (Mouritsen, 2009; Murphy, 2015). Seaweeds were previously more commonly eaten in 
the Northern European areas. Seaweed use has now been revived with the New Nordic kitchen 
(Mithril et al., 2012) in the Nordic countries and due to the influx of Asian food in Europe in 
general. Since ancient times, seaweed has been used in Asian countries as a functional food and 
medical herb, and it is therefore considered as an important resource for exploring new therapeutic 
compounds for humans (Moussavou et al., 2014). Multiple potential health-related actions of 
seaweed have been described (Motshakeri et al., 2014) and potential bioactive compounds from 
seaweed have been studied in a number of in vitro and animal studies. These include specific 
proteins and peptides, complex polysaccharides including sulphated polysaccharides and alginate, 
as well as polyphenols (e.g. phlorotannin), carotenoids and diterpenes (Gupta & Abu-Ghannam, 
2011). 
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Edible seaweeds are a particularly rich source of a variety of resistant dietary fibres, including 
xylans, carrageenan, fucoidan, laminaran and alginate. These different dietary fibres have different 
health-related properties (MacArtain et al., 2007). Some of the fibres are known to reduce 
glycaemia and insulin levels and some of them are known to improve satiety (Sharifuddin et al., 
2015) (MacArtain et al., 2007) (Lange et al., 2015). From other studies, it has been shown that some 
of the edible seaweed species have a positive effect on glucose metabolism in animal models 
(Motshakeri et al., 2014; Vaugelade et al., 2000). However, there is a scarcity of human studies on 
the short- and long-term effects of seaweed on these endpoints. Therefore, the main aim of this 
study was to investigate whether the two brown seaweeds, Laminaria digitata and Undaria 
pinnatifida, affect postprandial glucose, insulin and GLP-1 concentrations in healthy adults. 
Moreover, we sought to evaluate the effect of these two seaweed species on subjective appetite 
sensation using visual analogue scales (VAS) and an ad libitum meal.  
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2.  Methods 
2.1  Ethics and protocol registration 
The study was carried out at the Department of Nutrition, Exercise, and Sports (NEXS), in the 
section for Preventive and Clinical Nutrition, University of Copenhagen, Denmark. The study 
protocol was approved by the municipal Ethical Committee of Copenhagen (journal no.: H 
15004500) in accordance with the Helsinki-II declaration. The study was registered on 
Clinicaltrials.gov (ID# NCT02608372). Before entering the study, all participants gave their written 
consent after having received written and oral information about the study. 
2.2  Participants 
Twenty healthy participants aged 28.8 ± 5.4 y with body mass index (BMI) 21.4 ± 2.1 kg/m2 
were recruited through posters at the University of Copenhagen and via website advertisement on 
http://www.forsogsperson.dk and www.sundhed.dk. Participants were excluded, if they were 
suffering from systemic infections, had acute or chronic metabolic disorders, were smokers, were 
breastfeeding, pregnant or planning a pregnancy, were or had been drug addicts, or if they had an 
iodine related intolerance or allergy. Participants were also excluded if they had a history of surgical 
intervention for treatment of obesity, had been enrolled in any human dietary or medical 
intervention study less than 4 weeks before the study, or if they had habitual alcohol consumption 
above the maximal limit as recommended by the Danish Health Authorities (14 drinks per week for 
men or 7 drinks per week for women).  
2.3  Study design 
The study had a randomized, 3-way, blinded crossover design consisting of three test meals 
given in a random order to each participant on the test days, which were separated by at least 7 days 
for washout. Participants were instructed to refrain from all kinds of seaweed and paracetamol 48 h 
prior to and throughout each test day, except for what was provided. In addition, the participants 
were instructed to refrain from any caffeinated beverages including coffee, black, green, or white 
tea, cola, energy drinks and chocolate as well as alcohol during this same period. Furthermore, they 
should avoid intense physical activity 24 h proceeding each test day and until the following 
morning. 
 
109 
 
In the evening before each test day, the participants were fasting from 20:00, but drinking 0.5 L 
of water was required between 20:00 and 08:00 the next day and again 0.5 L during the test day 
(08:00-12:00). For each test day, the participants had to meet at the Department, in a 12-hour 
fasting state at 08:00 with minimal use of energy by either walking or cycling at a slow pace, by 
public transportation, or by car. 
Upon arrival, participants were asked to urinate and collect this baseline sample. Participants 
were then weighed, their height and waist circumference were measured, and they were instructed 
to lie down and rest for 10 min before measurement of baseline blood pressure (BP). A venflon 
catheter was afterwards inserted into the antecubital vein, preferably of the right arm, allowing 
repeated blood sampling throughout the day.  
2.4  Biological sampling 
The test subjects had three test visits, each with seven separate blood draws by trained 
phlebotomists. Blood samples were drawn as follows: baseline samples at timed intervals -20 min 
and then at 20, 40, 60, 90, 120 and 180 min. The blood was collected for plasma glucose analysis in 
3 mL FC-mixture tubes (VF-053SFC36, TERUMO Corporation, Tokyo, Japan). Blood collection 
for serum insulin and GLP-1 was collected in 4 and 6ml additive-free tubes (369032 and 366815 
from Becton Dickinson, Plymouth, UK). Samples for plasma collection were centrifuged 
immediately after sampling while serum tubes were allowed to stand at room temperature for 20 
min; serum and plasma were dispensed into cryotubes and subsequently frozen at -80oC. Samples 
were thawed and assayed after they had all been collected. 
2.5  Laboratory measures 
Plasma glucose was determined by a standard kit on an ABX Pentra 400 analyzer (Horiba ABX 
SAS, Montpellier, Cedex, France). Insulin was determined by solid-phase, two-site 
chemiluminescent immunometric assay, using Immulite 2000 XPi (Siemens Healthcare Diagnostic 
Ltd, Llaneris Gwynedd, United Kingdom). Serum concentrations of GLP-1 were determined using 
an enzyme-linked immunosorbent assay (ELISA) based kit (Multi Species GLP-1 total ELISA, 
EZGLP1T-36K) obtained from EMD Millipore, USA. The kit measures both the inactive and active 
form of GLP-1 (7-36- and 9-36amides) and was chosen based on recent findings (Bak et al. 2014). 
 
110 
 
2.6  Determination of mineral elements in seaweed samples 
The concentration of selected mineral elements in the seaweed samples was determined 
following the principles in EN15762:2009 (European Commitee for Standardisation, 2009). Briefly, 
subsamples of seaweed (approx. 0.3 g) were digested using 5 mL of concentrated nitric acid (SCP 
Science, France) in a microwave oven (Multiwave 3000, Anton Paar, Graz, Austria). Prior to 
analysis, the digests were diluted with milli-Q water and subsequently the total element 
concentration was determined using inductively coupled plasma mass spectrometry (ICP-QQQ-MS) 
(Agilent 8800, Agilent Technologies, Waldbronn, Germany). Quantification was done using 
external calibration with internal standardization. Analytical quality was assessed by running 
selected samples in duplicate (RSD values in the range 1-20% for all elements) and by including the 
certified reference material (CRM) ERM-CD200 Bladderwrack  (IRMM, 2016) in the analytical run 
(obtained results were in good agreement with certified target values). 
2.7  Determination of iodine in seaweed samples 
The content of iodine in the seaweed samples was determined following the principles in 
EN15111:2007 (European Committee for Standardisation, 2005). Briefly, subsamples of seaweed 
(approx. 0.3 g) were extracted using 4% TMAH in an oven at 90°C for 3 h. Prior to analysis the 
extracts were diluted with water and filtered and subsequently the iodine concentration 
determination using inductively coupled plasma mass spectrometry (Agilent 7500ce, Agilent 
Technologies, Japan). Quantification was done at m/z 127 using external calibration with internal 
standardization with tellurium at m/z 125. Analytical quality was assessed by running selected 
samples in duplicate (RSDpooled = 2,7% (N=3) and the use of the reference material CD200 
Bladderwrack, where the obtained results was in good agreement with the target value for iodine 
recently established in a collaborative trial (DTU Food, 2016).  
2.8  Measurements of subjective appetite sensations  
Appetite registration was measured at all three test days by repeated visual analogue scales 
(VAS). VAS was used as a replacement for a categorical questionnaire to register scores for satiety, 
hunger, prospective food intake, fullness, comfort, and ad libitum energy intake as continuous 
variables. The first appetite assessment was carried out before consumption of the test meal (after 
10-12 hours fasting). Subjects were hereafter instructed to register VAS every approximately 20 
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min, following a guideline on a tablet screen, until the last registration at 180 min postprandially 
after the ad libitum meal.  
The VAS registration was done using a digital tablet (Lenovo ThinkPad 10) running a VAS-
assessment program, Acqui (Laugesen, J. L. at XYZT, Denmark, www.sensory.dk). VAS was 
constructed as a digital horizontal line, equal to a 100 mm analogue line on a paper, with the 
question of interest set above the line. The extremes of the response options were indicated as 
vertical marks at each end of the line. The VAS equal to 0 and 100 mm is equivalent as follows: 
satiety (“I am completely empty” and “I cannot eat another bite”), hunger (“I am not hungry at all” 
and “I have never been more hungry”), prospective food intake (“How much do you think you can 
eat?” “Nothing at all” and “A lot”), fullness (“How full are you?” “I am totally full” and “Not full at 
all”) and comfort (“How comfortable do you feel?” “Not comfortable at all” and “Very 
comfortable”). The participants were instructed to assess each question and mark with a vertical line 
presented on the tablet screen. All data was downloaded from the tablets and quantified using Excel 
(Microsoft Denmark, Kgs. Lyngby, Denmark). 
2.9  Test meals 
The test meal was served in the morning at 08:45. A volume of 150 mL starchy drink consisting 
of 30 g of corn starch in water with 22 g sugar free lemonade powder (Fun One, Stevia lemonade 
with guava/lime, Kavli A/S Hvidovre, Denmark) was served with either of three different meals. 
They consisted of 5 g of Laminaria digitata (obtained from AlgAran Teoranta, Kilcar Co. Donegal, 
Ireland) or 5 g of Undaria pinnatifida (obtained from JFC Deutschland, Dusseldorf, Germany) or 5 
g of pea protein (Pea protein Mega 83%, Natur Drogeriet, Hørning, Denmark). The test meals were 
prepared by the kitchen staff at the Department of Nutrition, Exercise & Sports, University of 
Copenhagen.  The dried seaweed were soaked in 200 mL of water for 10 min, then rinsed and 
drained to remove excess water. Finally, they were cut into small pieces and added with 0.5 g iodine 
enriched salt (6.5 µg iodine), 0.2 g black pepper and 4 g of fresh lemon juice. Together with the test 
meal, a glass of 500 mL of drinking water was additionally served. The amount of 5 g of seaweed 
corresponds with the currently recommended maximal daily intake of this food in Denmark. The 
minor differences in contents of carbohydrate, fat, and protein in the three meals were adjusted with 
pea protein (83%), rapeseed oil and cornstarch.  
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Three hours after the test meal and immediately after the last VAS score participants were 
offered an ad libitum test meal to assess their hunger. The ad libitum meal consisted of 7987.6 kJ 
pasta with meat sauce, served with 250 mL water (energy: 554.5 kJ/100 g with macronutrient 
content (protein: 15.5 E %, carbohydrate: 54.5 E % and fat: 30.1 E %). The volunteers were given 
30 min to complete this meal. Table 1 and Table 2 show an overview of the various test meals.  
Table 1  
Nutrient composition of test meals (g/serving) 
 
Nutrient composition Laminaria 
digitata 
Undaria 
pinnatifida 
Pea protein, 
control 
Energy (kJ) 502.7 536.6 518.9 
Protein (g/serving) 0.8 1.1 1.0 
Fat (g/serving) 0.3 0.2 0.3 
Carbohydrate (g/serving) 27.3 29.2 28.8 
Dietary fibre (g/serving) 1.8 1.7 0.2 
Water (g) 206.7 206.7 206.7 
 (Dankost, 2015; Eurofins, 2016). 
Table 2 
Content of selected minerals in soaked, blotted Laminaria digitata and Undaria pinnatifida  
 
Mineral composition Laminaria digitata Undaria pinnatifida 
Arsenic (As) (mg/100g) 4.00 5.81 
Cadmium (Cd) (mg/100g) 0.018 0.137 
Chromium (Cr) (mg/100g) 0.048 0.096 
Iodine (I) (mg/100g) 164.6 32.0  
Zinc (Zn) (mg/100g)  5.53 4.00 
Calcium  (Ca) (g/100g) 2.01  1.27  
Magnesium (Mg) (g/100g) 0.683  0.406  
Potassium (K) (g/100g) 1.46  0.275  
Sodium (Na) (g/100g) 2.77  5.46  
The mineral contents were determined according to (Sloth, 2016) 
2.10  Statistical analysis 
Statistical analysis was performed using RStudio software (version 1.0.153, ©2009-2016 
Rstudio, Inc.) and R (version 3.4.1, R Core Team 2017). Graphs were prepared in GraphPad Prism 
version 7.0 (GraphPad Software Inc., 2017). The descriptive data is presented as mean ± standard 
deviation (SD), ± standard error (SE) or ± 95% Confidence Interval (CI). All variables were 
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checked for outliers and missing data. Dependent variables were inspected for homogeneity of 
variance and normal distribution using residuals plots and normal probability plots/histograms. 
Non-normally distributed data were logarithmically transformed and reassessed for normal 
distribution before further analysis. Glucose, insulin and GLP-1 responses and VAS scores were 
calculated as the incremental area under the curve, iAUC from baseline values. Blood 
concentrations of glucose, insulin and GLP-1 are presented as mmol/L, pmol/L and pmol/L 
respectively. Data for VAS questions are shown as mm within the range of 0-100mm. We used R 
lme4 (Bates et al., 2012) to additionally perform a linear mixed effects (LME) analysis  (ANOVA 
analysis) for repeated measures on all outcomes, with time and treatment as fixed effects and 
subject, sex and visit (randomization order) added as random effects. Post hoc pairwise 
comparisons were made with R multcomp (Hothorn, Bretz, &Westfall), at each time point with 
time 0 as a co-variate if the model showed statistical significance.  The same was applied for all 
VAS questions. All P-values < 0.05 were considered statistically significant.  
3.  Results 
3.1 Participant characteristics 
Recruitment of subjects started May 2015; forty subjects were screened and 20 healthy subjects 
(9 men and 11 women) were enrolled in the study. Table 3 shows the baseline characteristics of the 
subjects. All 20 volunteers completed the study, so the drop-out rate turned out to be 0%. 
Table 3 
Subjects characteristics at baseline 
 
Subject characteristics All (n = 20) 
 
 
Men (n = 9) 
 
Women (n = 11) 
  Age (y)      28.8 ± 5.4 30.3 ± 7.1        27.5 ± 3.4 
Height (cm)    171.3 ± 14.5   183.6 ± 10.0      160.7 ± 7.7 
Weight (kg)      63.6 ± 11.5     73.2 ± 9.7        55.9 ± 5.4 
BMI (kg/m2)      21.4 ± 2.2     21.6 ± 1.2        21.7 ± 1.9 
Waist circumference (cm)      76.4 ± 8.0     81.0 ± 6.7        71.8 ± 6.9 
Blood pressure, systolic (mm Hg)    110.3 ± 0.9   112.5 ± 1.5      108.3 ± 0.4 
Blood pressure, diastolic (mm Hg)      67.8 ± 0.2     63.6 ± 0.6        70.6 ± 0.6 
 Fasting blood glucose mmol/L 
Fasting  
       5.3 ± 0.4       5.3 ± 0.4          5.3 ± 0.5 
 asti  blood insulin pmol/L      45.5 ± 26,1     39.3 ± 17.3        50.6 ± 30.9 
 Fasting blood GLP-1 pmol/L      17.9 ± 7.0     17.5 ± 4.9        18.3 ± 8.3 
Numbers represent mean ± standard deviation. 
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3.2 Nutrient content and mineral elements 
 The nutrient and mineral contents varied between the two species, L. digitata and U. pinnatifida. 
In general, both of them had approximately 1.5 g higher dietary fibre content (Table 1) compared to 
the control meal. Furthermore L. digitata also has 5 times higher iodine content and almost 20 times 
higher K/Na ratio than U. pinnatifida (Table 2). 
3.3 Glucose, insulin and GLP-1 response 
There were no differences in iAUC for glucose or log-trans-formed insulin after intake of any of 
the two seaweed meals. Changes in glucose determinated by LME analysis  showed no  effect of the 
two meals compared with control. However, postprandial changes in insulin by LME analysis were 
different between the meals (P < 0.05). From the LME analysis for insulin  women had a lower 
insulin response at time 20 minutes (P = 0.004) after eating U. pinnatifida. Furthermore after eating 
L. digitata men had a lower insulin response at time 20 and 40 minutes (P = 0.026, P = 0.003, 
respectively), compared to control (Figure 1).  
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Figure 1. Effects of Undaria pinnatifida and Laminaria digitata on postprandial plasma insulin 
concentrations (pmol/L). Postprandial plasma insulin levels at 0, 20, 40, 60, 90, 120 and 180 min after the 
intake of control and seaweed meals. Values are represented as mean ± 95% CI (n=20). 
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The iAUC for GLP-1 was higher after intake of L. digitata when compared to control (P= 
0.017). The LME analysis for postprandial GLP-1 concentrations demonstrated an overall increase 
for L. digitata compared with control. Thus, the GLP-1 secretion was increased at time 120 minutes 
(P= 2.2e-05) after intake of the L. digitata meal compared to the control meal (see Figure 2).  
0
 
2
0
6
0
1
2
0
0
5
1 0
1 5
2 0
2 5
3 0
G L P - 1
T i m e  ( m i n )
p
m
o
l
/l
* * *
L a m i n a r i a  d i g i t a t a
U n d a r i a  p i n n a t i f i d a
C o n t r o l
 
Figure 2. Effects of Undaria pinnatifida and Laminaria digitata on postprandial plasma GLP-1 
concentrations (pmol/L). Postprandial blood GLP-1 levels at 0, 20, 60 and 120 min after the intake of control 
and seaweed meals. Values are represented as mean ± 95% CI (n=20). 
 
3.4 Appetite and comfort scores 
The postprandial changes in ratings of satiety, hunger, fullness, anticipated prospective food 
consumption, comfort and ad libitum energy are tabulated in Table 4. There were marked acute 
effects for all scores related to appetite, however there was no remaining effects after 200 min, no 
change in comfort at any time, and no effect on ad libitum energy intake at 200 min.  
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Satiety. There was a difference in satiety iAUC after intake of the test meals (P= 0.003), 
increasing it about 1314.1 ± 363.21 (SE) after intake of U. pinnatifida (P= 0.0002) and increasing it 
about 784.2 ± 367.02 (SE) after intake L. digitata  (P= 0.032) compared to control. 
Correspondingly, from the LME analysis an acute time dependent effect on the feelings of satiety 
(P= 0.009) were found. Thus, the subjects felt more satiated postprandially after ingesting U. 
pinnatifida, in particular at time 20 min (15.6 mm ± 3.7 (mean±SE), P= 302e-05) in comparison to 
the control meal. The response curves for satiety are presented in Figure 3. 
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Figure 3. Satiety scores postprandially after meals containing Laminaria digitata, Undaria pinnatifida or 
control (pea protein) in 20 healthy normal-weight subjects. VAS equal to 0 and 100 mm is equivalent to “I 
am completely empty” and “I cannot eat another bite, respectively.  # # #P< 0.001 for Undaria pinnatifida 
versus control. Values are represented as mean ± 95% CI (n=20). 
 
Hunger. Comparison of hunger iAUC showed no effects on the two test meals. However, from 
the LME model the feeling of hunger was affected after intake of the test meals (P= 0.016). Hunger 
was reduced due to the intake of the U. pinnatifida meal at time 20 min (-14.6 mm ± 4.1 
(mean±SE), P= 0.0004) and at time 70 min (-8.1 mm ± 4.1 (mean±SE), P= 0.048) compared to 
control (Figure 4). No specific time points were affected after intake of L. digitata.  
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Figure 4. Hunger scores postprandial after meals containing Laminaria digitata, Undaria pinnatifida or 
control (pea protein) in 20 healthy normal-weight subjects. VAS equal to 0 and 100 mm is equivalent to “I 
have never been more hungry” and “I am not hungry at all”, respectively ###P< 0.001 for Undaria pinnatifida 
versus control.  Values are represented as mean ± 95% CI (n=20). 
 
Fullness. Comparison of iAUC for the three meals demonstrated an effect on fullness after 
ingesting the test meals (P= 0.008), increasing it about 1247.1 ± 379.7 mm (mean±SE) after intake 
of U. pinnatifida (P= 0.001) compared to control. Changes in fullness were observed for both meals 
when analysing the data using LME (P= 0.019). From the following post hoc analysis, it appeared 
that the participants had an increased feeling of fullness after intake of the U. pinnatifida meal at 
time 20 min (14.5 mm ± 3.9 (SE), P= 0.0002) and time 50 min (10.0 mm ± 3.4 (SE), P = 0.01). The 
subjects also felt more full after intake of the L. digitata meal at time 20 min (7.1 mm ± 3.9 (SE), 
P= 0.041) (Figure 5).  
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Figure 5. Fullness scores postprandially after meals containing Laminaria digitata, Undaria pinnatifida or 
control (pea protein) in 20 healthy normal-weight subjects. VAS equal to 0 and 100 mm is equivalent to “I 
am totally full” (fullness), and “Not at all”, respectively. ###P< 0.0001 and, ##P< 0.001 for Undaria 
pinnatifida and *P< 0.05 for Laminaria digitata versus control. Values are represented as mean ± 95% CI 
(n=20). 
Anticipated prospective food consumption. There were no differences for iAUC between the 
three groups. The following LME analysis showed an acute time-dependent effect of the test meals 
(P= 0.034). The subjects had a reduced desire to eat after the U. pinnatifida test-meal compared to 
the control meal at the following time points: time 20 (-11.7 mm ± 3.4 (SE), P= 0.001), time 40 (-
7.7 mm ± 3.4 (SE), P= 0.02), time 50 (-8.8 mm ± 3.4 (SE), P= 0.01), time 70 min (-7.1 mm ± 3.4 
(SE), P= 0.04) and at time 100 min (-6.8 mm ± 3.4 (SE), P= 0.05) (see Figure 6). 
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Figure 6. Anticipated prospective food consumption scores postprandially after meals containing Laminaria 
digitata, Undaria pinnatifida or control (pea protein) in 20 healthy normal-weight subjects. VAS equal to 0 
and 100 mm is equivalent to “How much do you think you can eat?“ “Nothing at all” and “A lot”, 
respectively. # # #P< 0.001, # #P< 0.01 #P< 0.05 for Undaria pinnatifida versus control. Values are represented 
as mean ± standard error (n=20). 
 
Table 4 
Result for iAUC of all measured endpoints after ingestion of the three test meals 
 
Outcome Control 
Laminaria 
digitata 
 Undaria 
pinnatifida 
P -value 
iAUC 
P -value 
LMErm 
Biochemistry      
Glucose (mmol/L)   155.4 ± 19.8  -23.9 ± 20.2 29.5 ± 19.9      0.30      0.07  
Log-insulin (pmol/L)     76.1 ± 8.66  -8.30 ± 6.34 -5.19 ± 6.25      0.42      0.04* 
Glp-1 (pmol/L)   126.2 ± 80.4 176.6 ± 74.5 47.5 ± 73.4      0.02*      0.05* 
Appetite scores 
     
Satiety (mm) 1459.8 ± 394.1    719.3 ± 369.6    1282.1 ± 361.4     0.004 ** 0.009** 
Hunger (mm) 2481.7 ± 552.9   -1040.1 ± 557.2  641.6 ± 544.9      0.18      0.02* 
Fullness (mm) 1296.4 ± 386.7     568.2 ± 388.3   1247.2 ± 379.7    0.008 **      0.02* 
Prospective food- 
consumption (mm) 
1806.8 ± 429.3    -591.6 ± 443.2   -574.6 ± 33.5      0.32 
     0.03* 
Comfort (mm) 1182.9 ± 427.0    -279.0 ± 292.3      -5.82 ± 285.8      0.55      0.81 
Ad libitum (g)   512.7 ± 79.2  -99.8 ± 54.0      -5.23 ± 53.6        NA      0.131 
Comparison of iAUC for all outcomes using linear mixed model (LME) with iAUCoutcome ~ meal + visit, as the  
dependent variable. The fixed effect “meal” is presented as mean ± SE. The fixed effect “visit” is not shown as  
there was no effect observed for visit. P – values are obtained from the full model.  
The significant codes are:  *** for 0.001; ** for 0.01 and * for 0.05. NA; not applicable; the 1ad libitum could be compared using a 
linear mixed-effect model only.  
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4.  Discussion 
In this randomized controlled trial, we investigated the postprandial effects in healthy adults after 
meals containing whole brown seaweeds in order to study their potential for management of 
glycaemic and insulinemic responses, incretin effect, and appetite sensation. We used whole 
seaweeds in the meals as consumed by people in Asia, where seaweed salads with whole or 
chopped leafs are common. This provides minimal processing, thereby preserving the seaweed 
constituents. Consumption of whole seaweed may provide a combination of bioactive components 
which may be more effective than the sum of the individual compounds in seaweed when tested 
individually (Teas et al., 2013). The main findings from this study suggest that the brown seaweeds, 
Laminaria digitata and Undaria pinnatifida have effects on postprandial insulin and GLP-1 
concentrations in healthy adults after starchy meals. U. pinnatifida also significantly reduced 
postprandial insulin concentrations in women at 20 min.  
In previous studies, brown seaweeds were reported to contain potentially bioactive compounds 
that inhibited α-amylase and α-glucosidase enzymes in vitro and reduced blood glucose and plasma 
insulin concentrations in mice (Liu et al., 2016); (Kang et al., 2016); (Lordan, Smyth, Soler-Vila, 
Stanton, & Ross, 2013); (Lordan et al., 2011); (Zhang et al., 2007); (Aeda et al., 2007); (Hosokawa 
et al., 2010);  (Nwosu et al., 2011). Polyphenols, fucoxanthin and fatty acids found in L. digitata 
and U. pinnatifida have been reported to inhibit α-glucosidase activities resulting in a reduced rate 
of glucose liberation thereby reducing the postprandial rise in blood glucose. A crude polyphenol 
extract from a brown seaweed, Ascophyllum nodosum, reduced the fasting serum glucose level in 
diabetic mice by inhibiting the intestinal α-glucosidase (Zhang et al., 2007).  Other findings suggest 
that carotenoids such as fucoxanthin have potential to improve glycaemic control in mice 
(Hosokawa et al., 2010; Jung et al., 2012). U. pinnatifida contains from 1.77-2.89 mg of 
fucoxanthin per g of dry weight (Fung, Hamid, & Lu, 2013). In diabetic KK-Ay mice intake of 0.2% 
fucoxanthin in the feed reduced fasting blood glucose and plasma insulin concentrations compared 
with the control mice (Maeda et al., 2007). Fucoxanthin fed to diabetic and obese KK-Ay mice was 
also found to attenuate hyperglycaemia (Hosokawa et al., 2010). Other nonpolar components 
including oleic acid and linoleic acid found in L. digitata also seem to inhibit α-glucosidase in vitro, 
however their importance in vivo still needs to be investigated (Liu et al., 2016). Different Irish 
seaweed species have been shown to possess inhibitory properties on alpha glucosidase and to 
increase GLP-1 secretion. Subsequently, cold-water extracts of L. digitata were shown to have 
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potent inhibitory effects on DPP-4 similar to the effect of the well known DPP-4 inhibitor, 
berberine (Calderwood et al. 2013). Chin and colleagues (2015) report anti-diabetic potential of 
different seaweeds from Malaysia. Crude water extracts from the brown seaweeds, Paralia sulcata, 
Sargassum binderi and Turbinaria conoides strongly inhibited DPP-4 and stimulated secretion of 
the incretins, GLP-1 and GIP, from pGIP neo STC-1 cells in vitro. Various organic extracts from 
other Sargassum species (S. polycystum and S. wightii) have shown similar properties in vitro. 
Thus, different extracts from several brown seaweed species have been shown to inhibit DPP-4 at 
several concentrations (Unnikrishnan et al., 2015). The results from our study provide additional 
evidence that relatively small dietary intakes of whole seaweed may affect postprandial serum 
insulin and GLP-1 concentrations in healthy adults.  
These effects might be due to several factors including the specific nutrient content in seaweed. 
High contents of dietary fibre in the seaweed species used in our study may lead to reductions in 
blood glucose, insulin concentrations concentrations, however such effects are usually seen only at 
higher fibre intake levels than the 1.8 g provided in our study (Wolfram & Ismail-Beigi 2011). 
Brown seaweeds contain between 19.6-64.9% of soluble fibre depending on the species (Ruperez & 
Saura-Calixto, 2001) and the contents of around 40% observed for our batches is therefore not 
extraordinary. The soluble fibre from seaweed dissolves in water to form a viscous gel (Blackburn, 
Jarjjs, & Hanning, 1984), which might lead to a reduced rate of gastric emptying (Blackburn et al., 
1984) or simply to reduced substrate diffusion resulting in a reduction of the intestinal glucose 
absorption rate. Alternatively, glucose liberation from degradable polysaccharides such as starch 
may be delayed after entering into the duodenum thereby retarding the rate of glucose reaching the 
intestinal contents when seaweeds are consumed together with a meal rich in starch (here provided 
as a starchy drink). Seaweeds rich in dietary fibre have been reported to play an important role in 
glycaemic management (Sharifuddin et al., 2015). In a placebo-controlled crossover study involving 
30 healthy subjects, Wolf and colleagues (2002) found that an acid-induced viscosity complex 
containing 3.75 g alginate supplied together with a glucose beverage attenuated the postprandial 
glycaemic response, indicating that inhibition of enzymatic glucose release is not necessary for this 
response. However, the lack of reduction in postprandial blood glucose concentrations after intake 
of L. digitata and U. pinnatifida observed in our study could be explained to some extent by the low 
dose provided despite their high content of this dietary gel-forming fibre. In comparison, the control 
meal contained only a limited amount of pea fibre. Pea protein (10 g) combined with pea hull fibre 
(7 g)  is well known to have effects on postprandial blood glucose and this effect was not reduced 
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by adding insoluble hull fibre (Mollard et al., 2014). Therefore, our use of 5 g pea protein as control 
represents a low dose of another bioactive antiglycaemic meal component and may therefore have 
partially masked an effect of the seaweeds in this study.  
L. digitata and U. pinnatifida also increased satiety sensation and reduced any feelings of 
hunger. As opposed to the lack of effects of pea protein on postprandial measures of satiety 
(Mollard et al., 2014) our findings show that consumption of brown seaweed affects satiety and 
hunger. From the corresponding VAS questions, it appears that intake of whole U. pinnatifida and 
L. digitata affect several appetite related feelings for more than 1 h postprandially and satiety for 
more than two hours. This implies that these seaweed species are potential candidates to reduce 
energy intake for several hours after intake of just 5 g of dried U. pinnatifida and L. digitata, 
possibly because of its content of the polysaccharide, alginate, and perhaps other soluble dietary 
fibres having a satiating effect that may be due to bulking or to reduced gastric emptying rate. The 
data shows that average fasting levels of GLP-1 are lower than the postprandial GLP-1 
concentrations at time 20 min after all test meals with Laminaria, Undaria, or control. The 
increment correlates with previous findings showing that after ingestion of a liquid glucose load, 
nutrients reach the proximal duodenum about 6-8 min later (Deacon & Ahrén, 2011). The 
maximum serum concentrations (Cmax) of GLP-1 was reached at time 20 min for all test meals in 
accordance with a commonly observed peak-response approximately 30 min postprandially (Baggio 
& Drucker, 2007; Pala et al., 2010). However, as no data is available from baseline to 20 min and at 
60 min, it cannot be ruled out that the Cmax of GLP-1  was higher or occurred before or after time 20 
min. Significant differences in GLP-1 levels were seen at 120 min after intake of Laminaria 
compared to control. Similar findings were observed in an in vitro study, where laminarin, from 
Irish brown seaweed, was found to increase GLP-1 secretion and to inhibit DPP-4 (Calderwood et 
al., 2013). From our results, it can be speculated that the time course for laminarin to inhibit DPP-4 
is delayed because of the dietary fibre load from Laminaria causing a delayed absorption of the 
meal and as a result, there is an increase in GLP-1 levels again at time 120 min.  
This discovery could potentially benefit many people, both in terms of possibly helping in 
maintaining a given weight, as well as to potentially prevent and/or control weight gain; however, 
this needs to be carefully tested in longer-term trials. In support of this interpretation alginate from 
brown seaweed has been hypothesized to increase satiety by delaying gastric clearance, stimulating 
gastric stretch receptors, and attenuating nutrient absorption (Lange et al., 2015).  
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The analysis of nutrient and mineral contents showed that L. digitata and U. pinnatifida contain 
some protein but only small amounts of fat. Both of them, and especially L. digitate, are rich in 
minerals such as potassium (K), calcium (Ca) and magnesium (Mg), which have been hypothesized 
to improve glycaemic control (Song et al., 2006).  L. digitata and U. pinnatifida also contain zinc 
(Zn) and chromium (Cr) in relatively high amounts. Both minerals have been reported to improve 
blood sugar levels and improve the ability of insulin to bind to membrane receptors and to increase 
the transportation of glucose into muscle cells (Suliburska et al., 2014; Jou et al., 2010). However, 
care should be taken with some trace elements like iodine, where an upper tolerable intake level of 
iodine has been recommended at 600 µg/day for adults (European Commission, 2002). Despite the 
high iodine content in the test meals, the acute exposure was judged as safe for subjects who are not 
hypersensitive to iodine since single acute doses from foods are not known to give adverse effects 
(European Commission, 2002). However, caution may be needed in case of frequent consumption, 
as 0.36 g L. digitata and 1.9 g U. pinnatifida would exceed the recommended maximal average 
daily intake level of 600 µg/day. However, seaweed is a good natural resource of iodine that can 
help to increase thyroxine and reduce iodine deficiency disorder (Reinhardt et al., 1998).  
Further studies on isolated bioactive compounds from seaweed and a longer-term study with 
different groups of volunteers such as healthy subjects or subjects with insulin resistance are 
suggested in order to see the individual contributions of seaweed components to the satiating effects 
and to glucose/insulin maintenance over time. Cooking and processing of seaweed may also be of 
importance due to changes in nutrient and mineral levels and the resulting concentration of 
bioactive compounds in the meal. For example, iodine levels were decreased by cooking of L. 
digitata (the iodine is 99% water soluble) (Houa et al., 1997) and 99% of the iodine from U. 
pinnatifida was also found in the cooking water after 15 min of boiling (Ishizuki, 1989). Cooking 
may thus provide a means of reducing the iodine intake while increasing the exposure to other 
functional components. In addition, it would be interesting to investigate the effects of cooked vs. 
raw seaweed on glucose, insulin, incretins and appetite response and on food acceptability in a 
mixed-meal study. Further work is therefore needed in order to identify the bioactive compounds, 
longer-term effects, and mineral bioavailability in humans after L. digitata and U. pinnatifida 
intake. 
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5.  Conclusions 
This study did not show an effect of low amounts (5 g) of selected brown seaweeds on 
postprandial glycaemia but provides human trial evidence for an effect of the brown seaweeds on 
the insulinaemic response, GLP-1 secretion and appetite. Brown seaweed lowered the postprandial 
insulin response as well as hunger in humans exposed to a highly degradable linear starch and 
increased the postprandial feeling of satiety and fullness in healthy subjects of both sexes. 
Consumption of brown seaweed may be recommended for people with hyperglycaemic disorders 
provided issues with excessive iodine intake can be avoided by water extraction or cooking. 
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6. DISCUSSION 
The influence of seaweeds on α-amylase and α-glucosidase activities  
In the in vitro studies, crude extracts of dried edible seaweed, collected and purchased from 
different western and Asian countries, were investigated for their effects on carbohydrate-
digestive-enzymes. L. digitata and U. pinnatifida showed potent inhibiting effects on α-amylase 
and α-glucosidase, in mixed-type inhibition. These two brown seaweeds have a considerable 
potential for inhibition of α-amylase and α-glucosidase with efficiencies better than the red 
seaweeds tested here. Acetone and methanol extracts of U. pinnatifida and L. digitata had 
relatively higher α-amylase and α-glucosidase inhibitory activities.  
This result is in concordance with other studies where the brown seaweed, Ascophyllum 
nodosum, which is an Irish seaweed, was found to be a strong inhibitor of both α-amylase and α-
glucosidase activities at low concentrations (Lordan, Smyth, Soler-Vila, Stanton, & Ross, 2013; 
Nwosu et al., 2011). Another brown seaweed, Himanthalia elongata, also known as Sea 
spaghetti was also capable of inhibiting α-glucosidase activity (Mojica et al., 2014). 
Additionally, A. nodosum and H. elongata are capable of inhibiting α-glucosidase using water 
extracts (Lordan et al., 2013; Mojica et al., 2014). These findings further support the idea that 
brown seaweeds are highly potent in inhibiting carbohydrate digestion enzymes but also 
underline that several different bioactive components may be involved. 
Our results differ from another published study (Nagappan et al., 2017), in which the 
consumption of fresh seaweed of S. polycystum from Malaysia was shown to have higher 
inhibitory effect against α-amylase (IC50 0.58 ± 0.01 mg/mL) and α-glucosidase (IC50 0.69 ± 
0.02 mg/mL) compared to our dried S. polycystum. This was also observed by Kim et. al. (2008), 
who discovered a potent inhibitory activity of α-glucosidase by the fresh seaweed of Grateloupia 
elliptica from Korea. There are several possible explanations for these results such as the 
seaweed source, consumption of seaweeds being fresh or dry, climate and water conditions, that 
may cause differences in the potential of each seaweed preparation for inhibitory effects against 
these enzyme activities. However, a possible explanation for our results might be the degradation 
or removal of relevant bioactive compounds during the drying of the seaweeds. Drying also 
affects some differences in the seaweed nutrient composition (Matanjun et al., 2009). For 
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instance, a study conducted by Jenny et al. (1997) showed that the sun-dried seaweed, S. 
hemiphyllum, contains lower concentrations of total amino acids, total polyunsaturated fatty 
acids, minerals and total vitamin C compared with freeze-dried seaweed. 
Overall, these findings show that, the crude extracts of L. digitata and U. pinnatifida 
inhibited α-amylase and α-glucosidase activities. This implicates that these seaweeds may 
contribute to anti-hyperglycaemic effect. Further studies on the inhibitory effect of 
polyphenolics, alginates and fucoxanthin from seaweeds and the effect of selected dried edible 
seaweeds on human postprandial glycaemia were subsequently conducted to investigate its 
effects on anti-hyperglycaemic effect.  
 
Potential α-amylase and α-glucosidase inhibitors  
Polyphenolics, alginate and fucoxanthin present in brown seaweeds were bioactive 
compounds shown in this study to be α-amylase and α-glucosidase inhibitors. Several 
mechanisms may be involved in the inhibition of the enzymes activities. It was found that, L. 
digitata and U. pinnatifida both showed mixed-type inhibition. These results might be related to 
the polyphenolic compounds, alginate and fucoxanthin, as discussed below. 
 
Polyphenolic compounds 
Both preparations of the brown seaweeds, L. digitata and U. pinnatifida, contained high 
amounts of 2,5-dihydrobenzoic acids and small amount of gallic acids. Using 2,5-
dihydroxybenzoic acid and gallic acid (analytical-grade), it was found that 2,5-dihydroxybenzoic 
acid showed as the most effective α-amylase inhibitor with IC50 0.046 ± 0.004 mg/mL. In 
accordance with the present result, a previous study has demonstrated that 4-hydroxybenzoic 
acid (400 mg/L) (analytical grade) inhibited amylase activity (Wu, Shen, Han, Liu, & Lu, 2009) 
and other phenolic acid such as 2,4-dihydrobenzoic acid showed strong inhibitory effect against 
α-glucosidase enzyme compared to the standard of acarbose (Abdullah, Salim, & Ahmad, 2016). 
In this study, the kinetic analyses showed that both phenolic acids display mixed-type inhibition. 
In mixed-type inhibition, Km values increase with inhibitors since the inhibitors are competing 
with the substrates for a fixed number of active sites on α-amylase. Vmax decreases with the 
addition of 2,5-dihydroxybenzoic acid and gallic acid compared with control (no inhibitor). 
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These results indicate that the inhibitors do not bind to the active site of the enzyme. Instead they 
bind allosterically, to a different site on the α-amylase, thus affecting the enzyme-substrate 
complex and slowing the rate of reaction between starch and α-amylase. Contrary to this, 
epigallocatechin showed the lowest α-amylase inhibitory activity (IC50 0.504 ± 0.003mg/mL). 
The finding is in agreement with Yilmazer-Musa et.al. (2015) who found that catechins such as 
epigallocatechin are not strong inhibitors of α-amylase. This may be due to the lack of specific 
A- and B-ring hydroxyl groups to effectively interact with the catalytic site of the enzyme (Goh 
et al., 2015; Piparo & Nestlé, 2008; Yilmazer-Musa et al., 2015). 
 
Alginate  
Alginate is a complex polysaccharide found in brown seaweeds. The results of our study 
showed that L. digitata and U. pinnatifida display strong binding affinity to mAb LM7 
antibodies, which indicates high concentration of alginates in both. Alginate used in this study 
possessed the strongest inhibitory effect on α-amylase activity. Surprisingly, this alginate was a 
potent mixed type inhibitor against α-amylase, even stronger than crude extracts and acarbose. 
This result has not previously been reported in an in vitro study. Some authors have only 
reported that dietary fibres such as alginates promote a delayed glucose absorption and act on 
insulin response in T2D patients (Thorsdottir, Alpsten, Holm, Sandberg, & Tölli, 1991). Their 
results may be explained by the fact that alginate, which is a viscous fibre, slows gastric 
emptying rate and the intestinal absorption of glucose. Some other complex polysaccharide such 
as fucoidan found in brown seaweeds (A. nodusum) was reported to have the same findings 
where fucoidan inhibited  α-amylase and α-glucosidase, IC50  0.12-4.64 mg/mL and IC50 0.0013-
0.047 mg/mL, respectively (Kim, Rioux, & Turgeon, 2014). 
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Fucoxanthin 
It is interesting to note that among all five-seaweed species, U. pinnatifida had the 
strongest inhibitory effect against α-glucosidase. This effect was associated with the bioactive 
compound, fucoxanthin. The inhibition kinetic study indicates that fucoxanthin elicits mixed 
inhibition. In this study, fucoxanthin was found to be a strong inhibitor of α-glucosidase activity 
with a lower IC50 value than the acarbose. Fucoxanthin may therefore have the potential to 
reduce the rate at which α-glucosidase digests complex carbohydrates in the small intestine. 
These findings further support the idea of Hwang et al. (2015), where fucoxanthin isolated 
from acetone extract of S. hemiphyllum inhibited carbohydrate digestive enzymes such as α-
amylase and α-glucosidase (sucrose and maltase).  Jung et al. (2012) also reported that 
fucoxanthin showed potent inhibitory activity against protein tyrosine phosphatase 1B (PTP1B) 
and α-glucosidase.  Interestingly, Park et al. (2011) and Maeda et al. (2007) reported that 
fucoxanthin significantly reduced the fasting blood glucose concentration and plasma insulin 
concentration in C57BL/6J mice and KK-Ay mice, respectively.  
However, in accordance with previous studies, the mechanism by which fucoxanthin inhibits 
carbohydrate digestive enzymes and reduce the blood glucose has yet to be clarified. There are, 
however, some possible explanations based on our findings. The addition fucoxanthin showed it to 
be a mixed-type inhibitor, altering the Km and Vmax values. This usually happens by influencing 
the binding of substrates to the enzyme’s active site. Fucoxanthin probably binds to an allosteric 
site, a site different from the substrate binding in site. Fucoxanthin may therefore have the 
potential to reduce the rate at which α-glucosidase digests complex carbohydrates in the small 
intestine. 
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Influence of seaweeds’ bioactive compounds on carbohydrate digestion 
The results of this study indicate that polyphenolics, alginate and fucoxanthin found in L. 
digitata and U. pinnatifida are potent inhibitors of α-amylase and α-glucosidase activities. There 
are growing findings that polyphenols and dietary fibre may influence carbohydrate metabolism. 
In animal studies polyphenols found in food have attenuated postprandial glycaemic responses 
and improved acute insulin secretion and insulin sensitivity (Hanhineva et al., 2010) .   
There are various possible mechanisms involved to attenuate postprandial glycaemic 
responses. Based on our findings, the most plausible mechanism might be by inhibition of 
carbohydrate digestion enzymes. Alpha-amylase and α-glucosidase are the enzymes used to 
digest carbohydrates to glucose. Carbohydrate such as starch contain amylose (linear α-1,4-
linked glucose polymer) and amylopectin (linear α-1,4-linked glucose chains and α-1,6-linked 
branch chains). The inhibition of salivary and pancreatic α-amylase activity may reduce the 
hydrolysis of α-1,4-glucosidic linkages and its product, maltose. The inhibition of α-glucosidase 
activity in the small intestinal brush border will slow down the hydrolysis of the terminal α-1,4-
linked glucose, and the production of glucose. In addition, studies conducted in in vitro and 
animal models indicate that several flavonoids and phenolic acids such as ferulic, caffeic, and 
tannic acids, quercetin and catechin have been shown to inhibit glucose transport (Hanhineva et 
al., 2010; Nyambe-Silavwe et al., 2015; Sun et al., 2016). 
In this study, we also identified alginate in L. digitata and U. pinnatifida. Alginate is a 
source of dietary fibre. As mentioned before, alginate is a viscous dietary fibre in solution and 
was a potent inhibitor of α-amylase.  Possible effect of this alginate may be interference with the 
digestion of carbohydrate and the absorption of glucose. Ikeda & Kusano (1983) have indicated 
that several dietary fibre sources can inhibit digestive enzymes. According to Kapoor et al. 
(2016), the consumption of soluble fibre increases the viscosity of gut environments, reducing 
diffusion through the stationary water stratum and the accessibility of α-amylase to its substrates 
and thus decrease the enzyme activity. Soluble, viscous fibre like alginate may therefore slow the 
absorption of glucose by the small intestine. This soluble fibre is passing through into digestive 
system intact; since it is not broken down by the human digestive enzymes, this alginate does not 
raise blood glucose levels. When this soluble fibre reaches the large intestine, it will be 
fermented by the colonic microflora with the production of short fatty acids (SCFA). Some fibres 
are degraded in the large intestine and the rest being excreted in the stool. 
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Seaweeds influence the blood glucose and insulin levels 
The present study was designed to investigate the effect of selected edible seaweeds on the 
postprandial blood glucose and insulin concentrations following a starch load in humans. L. 
digitata and U. pinnatifida were tested for their effects on plasma glucose and serum insulin 
levels. 
The results show that there were no significant changes in iAUC of plasma glucose and 
serum insulin concentrations using these seaweeds when compared with the control meal. 
Although the changes were not significant, where P > 0.05 but both seaweed meals suggested a 
small decrease in plasma glucose and serum insulin concentrations compared with control meal. 
This was also statistically corroborated for serum insulin by using a mixed model showing that 
especially at the early time points after seaweed ingestion there was reduced responses. 
The results of this study will now be compared to the findings of previous works. In 
previous works, fucoxanthin from U. pinnatifida significantly lowered the fasting blood glucose 
concentration and the plasma insulin concentration in diet-induced obese  (C57BL/6J) mice 
(Park et al. 2011). After 9 weeks of feeding with fucoxanthin the insulin resistance index 
improved. However, in our study, we used the whole dried U. pinnatifida, and the 
bioaccessibility of the carotenoid may be affected by drying and also by the food matrix, which 
was quite low in fats. This may have resulted in a weaker inhibition of starch degradation and 
hence a weaker inhibition of the glycaemic response in the volunteers. 
The findings of our study suggested that alginate from brown seaweeds inhibited α-
amylase. In a study by Vaugelade et al. (2000), it was found that L. digitata, which contains 
alginate, strongly reduced blood glucose and insulin responses in Large White male pigs. In a 
human study, Paxman et al. (2008) used a crossover design to monitor the uptake of glucose. 
Overweight male subjects given 1.5 g of alginate from seaweed, revealed a significant decrease 
in glycaemia AUC. From these findings it seems quite clear that brown seaweeds that contain 
alginate influence blood glucose levels and have α-amylase inhibitory activities that may explain 
these actions. 
In another randomised study, a seaweed supplement that contained L. japonica and U. 
pinnatifida consumed by 10 subjects with T2D, resulted in significantly decreased fasting blood 
glucose levels (Kim, Kim, Choi, & Lee, 2008). This shows that the consumption of a seaweed 
supplement containing 30.1 g/day of total dietary fibre in T2D patients can result in lower levels 
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of fasting blood glucose. The authors state that the seaweed supplement may delay glucose 
absorption because it is rich in indigestible polysaccharide fibre. Although their preparation 
contains U. pinnatifida the authors do not discuss the potential influence of fucoxanthin on their 
findings. Similarly, to our human study results regarding insulin response and the in vitro 
findings on alginate and on fucoxanthin these findings may further support that brown seaweeds, 
particularly U. pinatifida, might be used as a potential functional food. 
 
Limitations and challenges 
This study had some limitations and challenges, which influenced the findings. One 
limitation was the focus on dried edible seaweeds to inhibit α-amylase and α-glucosidase 
activities and their potential effect on lowering the postprandial blood glucose and insulin 
concentrations following a starch load in human meal study. We used dried edible seaweeds 
compared with fresh edible seaweeds since it is much easier to buy dried edible seaweeds on the 
market compared with fresh seaweeds. 
As in Paper 1 and Paper 2, the investigation was limited by selected number of edible 
seaweed samples. All samples were collected at different locations such as Malaysia, Korea, 
Ireland, and Chile. It was therefore difficult to have fresh seaweeds at hand. Thus, dried 
seaweeds were used to study their effects and compare their enzyme inhibiting capabilities and 
their potential for lowering plasma glucose and serum insulin levels.  
Furthermore, the current study has only examined some of the potent bioactive compounds 
that inhibit enzyme activities. Only some of the compounds such as polyphenolics, alginate 
(Paper 1) and fucoxanthin (Paper 2) may have shown potent bioactive compounds due to the 
extraction methods and solvents used to extract the compounds from seaweeds. Other 
compounds may be liberated during digestion, but this process was not simulated in our setup 
but could be targeted in a follow-up study. 
Thirdly, in Paper 3, to explain some of the in vitro results, a human meal study was 
conducted in a randomized, 3-way, blinded crossover design.  Twenty healthy volunteers were 
recruited to participate in three meals containing either of two brown seaweeds or pea protein as 
placebo in random order and with at least one-week washout between meals. Before and up until 
3 h after the meal blood was collected for measurement of plasma glucose and serum insulin. 
The study was powered to observe an effect on the postprandial glucose iAUC provided dropout 
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was below 10%. The selection of pea protein may not be optimal since it has been found to affect 
postprandial glycaemia as well. This may have reduced any potential contrast with the seaweeds. 
In this study, we focused on the selected raw edible seaweeds (whole food). The study was not 
designed to investigate the effects of any specific bioactive compounds on the postprandial blood 
glucose and insulin levels. All meals also contained corn starch to provide an accessible substrate 
for the amylase and glucosidases in the upper digestive tract. We selected a linear starch needing 
only the amylase and glucosidase for degradation rather than using any branched starches which may 
use additional enzymes and/or be degraded more slowly. Incremental area under the curve (iAUC) 
for glucose was the primary end point and iAUC for insulin was secondary along with other 
statistical models. Repeated measures analyses were completed using linear mixed models. The 
mixed model gives some advantages by treating time as continuous variable rather than collapsing 
time as in the iAUC.  
We also investigated spontaneous energy intake after the last blood sample had been collected. 
The test meal may have contained too little energy and/or the time for the subsequent meal may have 
been too remote so that all subjects were quite hungry and ready to consume the energy expected for 
their body size. Also, the visual-analog scores for appetite, hunger and satiety indicate that effects of 
the seaweeds exist but only for the first hour or so. Only the smallest subjects consumed less than 
expected at the last test meal (data not shown), possibly because they had an adequate amount of 
energy from the test meal to feel some satiation still after 3 h. The test meals should therefore have 
been scaled to the energy needs of the subjects in order to get an optimal test of the seaweeds for 
effects on subsequent energy intake 3 h after intake.  
We carried out the investigation on healthy subjects rather than in pre-diabetics. This was 
done because the immediate effect on starch degradation in the upper gastrointestinal tract was 
expected to be independent of the presence of glycaemia per se. In a longer-term study the effect 
on glycaemia in pre-diabetic and diabetic patients would be much more relevant. 
The overall strengths of the study were the randomisation reducing confounding and the 
crossover design reducing bias because each subject is their own control. It was also a strength 
that the meals were well accepted by the volunteers and that the drop-out rate was low to help 
keep a reasonable power. The major weaknesses are the still limited size of the study, which 
could cause a few individuals to strongly affect the results. Moreover, the amount of seaweed 
provided and the selection of pea protein for the control meal and the use of the same meal size 
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for all volunteers, independent of their energy needs may have reduced the ability to observe 
effects of the seaweeds in this study. 
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7. CONCLUSIONS   
The main aim of this thesis work was to investigate the potential of crude extracts of dried 
edible seaweeds to inhibit α-amylase and α-glucosidase activities and to examine the effect of 
selected edible seaweeds on the postprandial blood glucose and insulin levels following a starch 
load in a human meal study. Based on the three papers, the findings can be concluded as follows: 
In Paper 1 and Paper 2, the dried edible seaweeds, U. pinnatifida and L. digitata, showed 
effective inhibition of α-amylase and α-glucosidase activities, with both showing mixed-type 
inhibition. Alpha-amylase and α-glucosidase inhibitors play important roles in achieving better 
glycaemic control independent of insulin, potentially retarding glucose liberation from starches. 
U. pinnatifida and L. digitata containing phenolic acids and alginates inhibited α-amylase 
activities while fucoxanthin from U. pinnatifida inhibited α-glucosidase activities, showing 
chemical diversity with a possibly use for future functional foods.  
In Paper 3, we investigated the effect of raw U. pinnatifida and L. digitata on the 
postprandial blood glucose and insulin concentrations following a starch load in a human meal 
study. In a randomized, 3-way blinded crossover trial; there was no significant effect in mean 
difference of plasma glucose and serum insulin incremental areas under the curve with the 
consumption of 5 g of seaweeds compared with the control meal (P > 0.05). However, insulin 
was affected in a mixed model and at several time points. Also increased satiety and fullness 
iAUC and decreased hunger and prospective food consumption iAUC were observed after intake 
of U. pinnatifida, while no effects were observed on energy intake 3 hours after the seaweed test 
meal.  
Overall, relatively small amounts, only 5 g, of brown seaweeds have no effect on the 
incremental area under the curve for plasma glucose but affect several secondary endpoints 
within the first 1-2 hours after ingestion. It is therefore not possible to conclude that the 
inhibition of -amylase and -glucosidase observed in vitro can affect postprandial blood 
glucose while it may indirectly affect insulin, GLP-1 and feeling of satiety, fullness, prospective 
food intake and hunger up to 1½ hours after a meal with 5 g of brown seaweed. 
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8. PERSPECTIVES 
The future perspectives are to further investigate seaweeds for effects on postprandial 
glycaemia and possibly to apply the potential bioactive compounds from seaweeds in 
populations with hyperglycaemia. If possible, different cooking methods or preparation of 
seaweed meals can be done to compare the findings and factors that affect the plasma glucose 
and serum insulin levels. Especially due to the high levels of iodine and certain other elements it 
may be of particular value to find methods for preparing seaweeds that reduce these components 
while keeping the alginate and fucoxanthin. The consumption of fresh edible seaweeds would 
also provide for an interesting future study about how freshness influences the bioactive and 
macronutrient compositions of the diet, which could be beneficial in reducing plasma glucose 
and serum insulin levels. 
Regarding the study design for both meal studies and longer-term studies, larger numbers 
of participants should be recruited as they would represent better the population at large and may 
reduce the impact of outliers. In a longer-term study the effect on glycaemia in pre-diabetic and 
diabetic patients would be much more relevant.  
The concluding perspective is that bioactive compounds from U. pinnatifida and L. 
digitata that has the potential to inhibit carbohydrate digestive enzymes may be potential 
applications in the formulation of functional food.  The bioactive compound can be added as 
food ingredient in food or beverages products to produce functional food that provide health 
benefits to human.  
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